<!DOCTYPE article
 PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2 20190208//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="preprint"><?all-math-mml yes?><?use-mml?><?origin ukpmcpa?><front><journal-meta><journal-id journal-id-type="nlm-ta">bioRxiv</journal-id><journal-title-group><journal-title>bioRxiv : the preprint server for biology</journal-title></journal-title-group><issn pub-type="ppub"/></journal-meta><article-meta><article-id pub-id-type="manuscript">EMS155982</article-id><article-id pub-id-type="doi">10.1101/2022.10.18.512649</article-id><article-id pub-id-type="archive">PPR559962</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Snf1/AMPK fine-tunes TORC1 signaling in response to glucose starvation</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Caligaris</surname><given-names>Marco</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Nicastro</surname><given-names>Raffaele</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="corresp" rid="CR1">*</xref></contrib><contrib contrib-type="author"><name><surname>Hu</surname><given-names>Zehan</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Tripodi</surname><given-names>Farida</given-names></name><xref ref-type="aff" rid="A2">2</xref></contrib><contrib contrib-type="author"><name><surname>Hummel</surname><given-names>Johannes Erwin</given-names></name><xref ref-type="aff" rid="A3">3</xref></contrib><contrib contrib-type="author"><name><surname>Deprez</surname><given-names>Marie-Anne</given-names></name><xref ref-type="aff" rid="A5">5</xref></contrib><contrib contrib-type="author"><name><surname>Winderickx</surname><given-names>Joris</given-names></name><xref ref-type="aff" rid="A5">5</xref></contrib><contrib contrib-type="author"><name><surname>Rospert</surname><given-names>Sabine</given-names></name><xref ref-type="aff" rid="A3">3</xref><xref ref-type="aff" rid="A4">4</xref></contrib><contrib contrib-type="author"><name><surname>Coccetti</surname><given-names>Paola</given-names></name><xref ref-type="aff" rid="A2">2</xref></contrib><contrib contrib-type="author"><name><surname>Dengjel</surname><given-names>Jörn</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>De Virgilio</surname><given-names>Claudio</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="corresp" rid="CR1">*</xref></contrib></contrib-group><aff id="A1"><label>1</label>Department of Biology, University of Fribourg, CH-1700 Fribourg, Switzerland</aff><aff id="A2"><label>2</label>Department of Biotechnology and Biosciences, University of Milano-Bicocca, 20126 Milano, Italy</aff><aff id="A3"><label>3</label>Institute of Biochemistry and Molecular Biology, Faculty of Medicine, University of Freiburg, D-79104 Freiburg, Germany</aff><aff id="A4"><label>4</label>Signalling Research Centres BIOSS and CIBSS, University of Freiburg, D-79104 Freiburg, Germany</aff><aff id="A5"><label>5</label>Functional Biology, KU Leuven, 3001 Heverlee, Belgium</aff><author-notes><corresp id="CR1">
<label>*</label>For correspondence: <email>Raffaele.Nicastro2@unifr.ch</email> and <email>Claudio.DeVirgilio@unifr.ch</email>
</corresp></author-notes><pub-date pub-type="nihms-submitted"><day>20</day><month>10</month><year>2022</year></pub-date><pub-date pub-type="preprint"><day>18</day><month>10</month><year>2022</year></pub-date><permissions><ali:free_to_read/><license><ali:license_ref>https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref><license-p>This work is licensed under a <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">CC BY-NC-ND 4.0 International license</ext-link>.</license-p></license></permissions><abstract><p id="P1">The AMP-activated protein kinase (AMPK) and the target of rapamycin complex 1 (TORC1) are central kinase modules of two opposing signaling pathways that control eukaryotic cell growth and metabolism in response to the availability of energy and nutrients. Accordingly, energy depletion activates AMPK to inhibit growth, while nutrients and high energy levels activate TORC1 to promote growth. Both in mammals and lower eukaryotes such as yeast, the AMPK and TORC1 pathways are wired to each other at different levels, which ensures homeostatic control of growth and metabolism. In this context, a previous study (Hughes Hallet et. al, 2015) reported that AMPK in yeast, <italic>i</italic>.<italic>e</italic>. Snf1, plays a role in short-term downregulation of TORC1 activity upon acute glucose starvation, but the underlying mechanism has remained elusive. Using a combination of unbiased mass spectrometry (MS)-based phosphoproteomics, genetic, biochemical, and physiological experiments, we show here that Snf1 contributes to glucose starvation-induced short-term TORC1 inactivation primarily through the TORC1-regulatory protein Pib2. Our data, therefore, extend the function of Pib2 to a hub that integrates both glucose and, as reported earlier, glutamine signals to control TORC1. We further demonstrate that Snf1 phosphorylates the TORC1 effector kinase Sch9 within its N-terminal region and thereby antagonizes the phosphorylation of a C-terminal TORC1-target residue within Sch9 itself that is critical for its activity. The consequences of Snf1-mediated phosphorylation of Pib2 and Sch9 are physiologically additive and sufficient to explain the role of Snf1 in short-term inhibition of TORC1 in acutely glucose-starved cells.</p></abstract></article-meta></front><body><sec id="S1" sec-type="intro"><title>Introduction</title><p id="P2">The eukaryotic target of rapamycin complex 1 (TORC1/mTORC1) signaling pathway serves as a central hub that couples growth signals with metabolic circuits that define cell growth. The TORC1 protein kinase activity is positively regulated by intracellular nutrients (<italic>e</italic>.<italic>g</italic>., amino acids, glucose, and lipids), high energy levels, as well as extracellular growth factors (<italic>e</italic>.<italic>g</italic>., insulin and insulin-like growth factor 1 [IGF-1]). In response to these cues, it favors the increase of cellular mass by stimulating lipid, nucleotide, and protein synthesis and by inhibiting the autophagic recycling of macromolecules (<xref ref-type="bibr" rid="R1">Albert and Hall, 2015</xref>; <xref ref-type="bibr" rid="R34">González and Hall, 2017</xref>; <xref ref-type="bibr" rid="R56">Laplante and Sabatini, 2012</xref>; <xref ref-type="bibr" rid="R60">Liu and Sabatini, 2020</xref>). TORC1 function is embedded in as yet incompletely understood feedback loops, allowing it to act as a metabolic rheostat. Uncoupling TORC1 from this regulatory network is associated with dramatically altered lifespan in unicellular organisms such as yeast and with diseases such as cancer, immunodeficiency, type 2 diabetes, and neurodegeneration in humans (<xref ref-type="bibr" rid="R56">Laplante and Sabatini, 2012</xref>).</p><p id="P3">The structure of TORC1 in its core is highly conserved among eukaryotes and consists of a dimer of a heterotrimeric complex that harbors a TOR serine/threonine protein kinase (Tor1 or Tor2 in the budding yeast <italic>Saccharomyces cerevisiae</italic> or mTOR in mammals) and two regulatory proteins (yeast Kog1 and Lst8, or the orthologous mammalian Raptor [regulatory-associated protein of mTOR] and LST8 [mLST8], respectively (<xref ref-type="bibr" rid="R121">Wullschleger et al., 2006</xref>)). Additional seemingly non-conserved proteins, such as Tco89 in yeast or the proline-rich Akt substrate of 40 kDa (PRAS40) and the DEP domain-containing mTOR- interacting protein (DEPTOR) in mammals, associate with this core complex to adapt its function to species-specific requirements (<xref ref-type="bibr" rid="R62">Loewith et al., 2002</xref>; <xref ref-type="bibr" rid="R82">Peterson et al., 2009</xref>; <xref ref-type="bibr" rid="R89">Reinke et al., 2004</xref>; <xref ref-type="bibr" rid="R94">Sancak et al., 2007</xref>). TORC1 mainly functions at the vacuolar/lysosomal surface both in lower eukaryotes like the yeast <italic>S. cerevisiae</italic> as well as in higher eukaryotes such as <italic>Drosophila</italic> and mammals. At this location, TORC1 binds to and/or is regulated by the conserved heterodimeric Rag GTPases (<italic>i</italic>.<italic>e</italic>. yeast Gtr1 bound to Gtr2, or mammalian RagA or B bound to RagC or D). These heterodimers associate with structurally conserved protein complexes coined the EGO (exit from rapamycin-induced growth arrest) ternary complex in yeast (EGO-TC; comprising Ego1/Mhe1, Ego2, and Ego3/Slm4) or the pentameric Ragulator complex in mammals (comprising p18, p14, MP1, C7orf59, and HBXIP) (<xref ref-type="bibr" rid="R6">Bar-Peled et al., 2012</xref>; <xref ref-type="bibr" rid="R29">Dubouloz et al., 2005</xref>; <xref ref-type="bibr" rid="R87">Powis et al., 2015</xref>; <xref ref-type="bibr" rid="R93">Sancak et al., 2010</xref>). The complexes are anchored to vacuolar/lysosomal membranes through N-terminally lipidated Ego1 or p18, respectively (<xref ref-type="bibr" rid="R10">Binda et al., 2009</xref>; <xref ref-type="bibr" rid="R72">Nada et al., 2009</xref>; <xref ref-type="bibr" rid="R87">Powis <italic>et al</italic>., 2015</xref>; <xref ref-type="bibr" rid="R93">Sancak <italic>et al</italic>., 2010</xref>). The Rag GTPases adopt one of two stable conformations, an active state in which Gtr1 or RagA/B is bound to GTP and Gtr2 or RagC/D to GDP, and an inactive state with the opposite GTP/GDP-loading configuration. The respective nucleotide-loading states are primarily preserved by crosstalk between the Rag GTPases and are regulated via a set of conserved GTPase activating (GAP) protein complexes (<italic>i</italic>.<italic>e</italic>. yeast SEACIT/mammalian GATOR1 and yeast Lst4-Lst7/mammalian FNIP-FLCN acting on Gtr1/RagA/B and Gtr2/RagC/D, respectively (<xref ref-type="bibr" rid="R5">Bar-Peled et al., 2013</xref>; <xref ref-type="bibr" rid="R79">Panchaud et al., 2013a</xref>; b; <xref ref-type="bibr" rid="R81">Péli-Gulli et al., 2015</xref>; <xref ref-type="bibr" rid="R83">Petit et al., 2013</xref>; <xref ref-type="bibr" rid="R99">Shen et al., 2017</xref>; <xref ref-type="bibr" rid="R111">Tsun et al., 2013</xref>)), which mediate cytosolic and/or vacuolar/lysosomal amino acid levels through different mechanisms (<xref ref-type="bibr" rid="R34">González and Hall, 2017</xref>; <xref ref-type="bibr" rid="R60">Liu and Sabatini, 2020</xref>; <xref ref-type="bibr" rid="R73">Nicastro et al., 2017</xref>). Notably, in flies and mammals, but likely not in yeast (<xref ref-type="bibr" rid="R86">Powis and De Virgilio, 2016</xref>), the Rag-GTPase tethered, lysosome-associated TORC1 pool is also allosterically activated by the small GTPase Rheb (Ras homolog enriched in brain) in its GTP-bound form (<xref ref-type="bibr" rid="R3">Anandapadamanaban et al., 2019</xref>; <xref ref-type="bibr" rid="R15">Buerger et al., 2006</xref>; <xref ref-type="bibr" rid="R63">Long et al., 2005</xref>; <xref ref-type="bibr" rid="R90">Rogala et al., 2019</xref>). Rheb responds, among other factors, to energy levels that are mainly integrated by the Rheb GAP complex (comprising TSC1, TSC2, and TBC1D7), which is also known as Rhebulator (<xref ref-type="bibr" rid="R25">Demetriades et al., 2014</xref>; <xref ref-type="bibr" rid="R28">Dibble et al., 2012</xref>; <xref ref-type="bibr" rid="R47">Inoki et al., 2003a</xref>; <xref ref-type="bibr" rid="R63">Long <italic>et al</italic>., 2005</xref>; <xref ref-type="bibr" rid="R108">Tee et al., 2003</xref>; <xref ref-type="bibr" rid="R122">Yang et al., 2017</xref>). This mechanism relies on the AMP-activated protein kinase (AMPK), a key regulator of cellular energy charge that inactivates mTORC1 indirectly by phosphorylating TSC2 and thereby activating the GAP activity of Rhebulator (<xref ref-type="bibr" rid="R48">Inoki et al., 2003b</xref>; <xref ref-type="bibr" rid="R98">Shaw et al., 2004</xref>).</p><p id="P4">AMPK functions within a conserved heterotrimeric complex encompassing a catalytic α subunit (yeast Snf1 or mammalian α1/2), and one of each β- (yeast Gal83, Sip1, and Sip2 or mammalian β1/2) and γ- (yeast Snf4 or mammalian γ1/2/3) regulatory subunits (<xref ref-type="bibr" rid="R16">Carling, 2004</xref>; <xref ref-type="bibr" rid="R33">Ghillebert et al., 2011</xref>; <xref ref-type="bibr" rid="R41">Hedbacker and Carlson, 2008</xref>). In line with its denomination, mammalian AMPK is allosterically activated by AMP. This seems not to be the case for Snf1, since the latter is mainly activated by the absence of glucose in the medium and since regulatory sites have been characterized that preferably bind ADP instead of AMP (<xref ref-type="bibr" rid="R21">Coccetti et al., 2018</xref>; <xref ref-type="bibr" rid="R43">Herzig and Shaw, 2018</xref>; <xref ref-type="bibr" rid="R67">Mayer et al., 2011</xref>; <xref ref-type="bibr" rid="R119">Wilson et al., 1996</xref>). Nonetheless, both mammalian AMPK and yeast Snf1 are similarly activated by phosphorylation of a conserved threonine (Thr) within their activation loop (yeast Thr<sup>210</sup> or mammalian Thr<sup>172</sup>) that is executed by specific upstream kinases (yeast Sak1, Tos3, and Elm1 or mammalian LKB1 and CaMKK2) (<xref ref-type="bibr" rid="R35">González et al., 2020</xref>; <xref ref-type="bibr" rid="R41">Hedbacker and Carlson, 2008</xref>). In yeast, this phosphorylation event is reversed by the type I protein phosphatase Glc7 (combined with the regulatory Reg1 subunit) specifically when extracellular glucose is sufficiently available (<xref ref-type="bibr" rid="R65">Ludin et al., 1998</xref>; <xref ref-type="bibr" rid="R68">McCartney and Schmidt, 2001</xref>). Both AMPK and Snf1 are also wired to control mTORC1/TORC1 via Raptor and Kog1, respectively, albeit through different mechanisms. Accordingly, AMPK has been reported to inhibit mTORC1 through direct phosphorylation of Raptor (<xref ref-type="bibr" rid="R37">Gwinn et al., 2008</xref>). Although one of the respective AMPK target residues in Raptor is conserved in Kog1, Snf1 does not control TORC1 through this residue (Ser<sup>959</sup>;(<xref ref-type="bibr" rid="R53">Kawai et al., 2011</xref>)), but rather through phosphorylation of Ser<sup>491</sup> and Ser<sup>494</sup>, thereby promoting the formation of TORC1 bodies during prolonged glucose starvation (<xref ref-type="bibr" rid="R46">Hughes Hallett et al., 2015</xref>; <xref ref-type="bibr" rid="R104">Sullivan et al., 2019</xref>). Moreover, upon acute glucose starvation, Snf1 also plays a role in short-term downregulation of TORC1, which is independent of TORC1-body formation, but the underlying mechanism is still elusive (<xref ref-type="bibr" rid="R46">Hughes Hallett <italic>et al</italic>., 2015</xref>).</p><p id="P5">To address the outstanding question of how Snf1 contributes to TORC1 inhibition following glucose starvation, we used a yeast strain in which Snf1 can be conditionally inactivated by addition of the ATP-analog 2NM-PP1 and applied a mass spectrometry (MS)-based phosphoproteomics strategy that combines <italic>in vivo</italic> proteomics with on-beads <italic>in vitro</italic> kinase assays (OBIKA) to identify direct Snf1 target residues on a global scale. This approach not only allowed us to uncover the currently largest set of Snf1-dependent phosphorylation events in <italic>S. cerevisiae</italic>, but also pinpointed several potential Snf1 targets within the TORC1 signaling pathway. Employing genetic, biochemical, and physiological experiments, we demonstrate that Snf1 contributes to the glucose starvation-induced short-term inactivation of TORC1 primarily through the regulatory protein Pib2. In addition, Snf1 specifically phosphorylates the TORC1 effector kinase Sch9 and thereby antagonizes the phosphorylation of a C-terminal TORC1-target residue within Sch9 that is critical for its activity. The consequences of Snf1-mediated phosphorylation of Pib2 and Sch9 are physiologically additive and sufficient to mediate an appropriate short-term response of TORC1 to acute glucose starvation.</p></sec><sec id="S2" sec-type="results"><title>Results</title><sec id="S3"><title>Snf1 grants proper downregulation of TORC1 in glucose-starved cells</title><p id="P6">To study how Snf1 contributes to the rapid inhibition of TORC1 in glucose-starved cells, we used a strain in which the <italic>SNF1</italic> locus expresses the <italic>snf1</italic><sup><italic>I132G</italic></sup> -allele (Snf1<sup>as</sup>) that is sensitive to the ATP-analog 2-naphthylmethyl pyrazolopyrimidine 1 (2NM-PP1), but supports normal growth on sucrose or low glucose-containing media (<xref ref-type="bibr" rid="R101">Shirra et al., 2008</xref>; <xref ref-type="bibr" rid="R123">Zaman et al., 2009</xref>). In our control experiments, the Snf1<sup>as</sup> allele was appropriately activated by its upstream protein kinases, as assessed by the rapid increase in Thr<sup>210</sup> phosphorylation that was comparable to wild-type Snf1, and it mediated the rapid phosphorylation of a synthetic AMPK activity reporter substrate (ACC1-GFP) in glucose-starved cells, albeit to a lower extent than wild-type Snf1 (<xref ref-type="fig" rid="F1">Fig. 1A</xref> and Supplementary figure 1). As expected, the presence of 2NM-PP1 fully abrogated the activity of Snf1<sup>as</sup>, but not that of wild-type Snf1 (<xref ref-type="supplementary-material" rid="SD1">Supplementary figure 1</xref>). Compared to DMSO-treated (control) <italic>snf1</italic><sup><italic>as</italic></sup> cells, 2NM-PP1-treated <italic>snf1</italic><sup><italic>as</italic></sup> cells were also significantly compromised in TORC1 downregulation, as detected by measuring the phosphorylation of Thr<sup>737</sup> in Sch9, a proxy for TORC1 activity (<xref ref-type="bibr" rid="R114">Urban et al., 2007</xref>), specifically during the time frame of 6-15 min following glucose starvation (<xref ref-type="fig" rid="F1">Fig. 1A-D</xref>). Because loss of Snf1 caused a comparable defect that was independent of the presence or absence of 2NM-PP1 (<xref ref-type="fig" rid="F1">Fig. 1A</xref>), our data corroborate the previous notion that Snf1 activity is required for proper TORC1 inhibition during the early phase of glucose starvation (<xref ref-type="bibr" rid="R46">Hughes Hallett <italic>et al</italic>., 2015</xref>). Based on these observations, we reasoned that unscheduled hyperactivation of Snf1 might also inhibit TORC1 even in cells growing in a glucose-rich environment. This was indeed the case as loss of Reg1, the regulatory subunit that instructs the PP1 Glc7 to dephosphorylate pThr<sup>210</sup> and thus inactivate Snf1 (<xref ref-type="bibr" rid="R65">Ludin <italic>et al</italic>., 1998</xref>; <xref ref-type="bibr" rid="R95">Sanz et al., 2000</xref>), resulted in hyperphosphorylation of Snf1-Thr<sup>210</sup> that was accompanied by a significant reduction in TORC1 activity (<xref ref-type="fig" rid="F1">Fig. 1E</xref>). In line with these data, loss of Reg1, like loss of the TORC1-regulatory Rag GTPase Gtr1, rendered cells sensitive to sub-inhibitory levels of rapamycin, while loss of Snf1 conferred slight resistance to rapamycin (<xref ref-type="fig" rid="F1">Fig. 1F</xref>).</p><p id="P7">It has previously been demonstrated that TORC1 activity can be transiently (on a short-time scale of 1-5 min) activated by the addition of a nitrogen source such as glutamine to nitrogen starved cells (<xref ref-type="bibr" rid="R103">Stracka et al., 2014</xref>). Based on our results above, we therefore assumed that the respective transient activation of TORC1 may be reduced in the absence of glucose, because we expected this to activate Snf1 and therefore (directly or indirectly) inhibit TORC1. Indeed, when <italic>snf1</italic><sup><italic>as</italic></sup> cells were starved for both glucose and glutamine at the same time, TORC1 was rapidly inactivated and could only be transiently reactivated when cells were refed with either glucose alone or with glucose and glutamine combined (<xref ref-type="fig" rid="F2">Fig. 2A-D</xref>), but not when refed with glutamine alone (<xref ref-type="fig" rid="F2">Fig. 2E and 2F</xref>). In the latter case, however, 2NM-PP1 treatment, and hence inactivation of Snf1<sup>as</sup>, was able to partially restore the transient glutamine-mediated TORC1 activation (<xref ref-type="fig" rid="F2">Fig. 2E and &gt;F</xref>). From these experiments, we infer that Snf1 not only contributes to proper TORC1 downregulation in glucose-starved cells, but also helps to prevent the transient reactivation of TORC1 in glutamine refed, glucose-starved cells.</p></sec><sec id="S4"><title>Global phosphoproteomics identifies potential Snf1 targets within the TORC1 signaling pathway</title><p id="P8">To dissect the mechanisms by which Snf1 impinges on TORC1 signaling, we decided to perform a set of stable isotope-labeling by amino acids in cell culture (SILAC)-based quantitative phosphoproteomic experiments, similarly as recently described (<xref ref-type="bibr" rid="R45">Hu et al., 2021</xref>). For <italic>in vivo</italic> analyses, <italic>snf1</italic><sup><italic>as</italic></sup> cells were grown in three different SILAC media supporting the comparison of three experimental conditions (<xref ref-type="fig" rid="F3">Fig. 3A</xref>). Cells grown in full medium (2% glucose, light label) served as control. The cellular response to glucose starvation was analyzed after 5 and 15 minutes (shift to 0.05% glucose, medium and heavy label, respectively). To discriminate potential Snf1 target sites from sites being regulated by other kinases, concomitantly to the glucose downshift, cells were treated, or not, with the selective ATP-competitive inhibitor 2NM-PP1. Snf1 target sites should be positively regulated in the control set and not, or significantly less, in the 2NM-PP1-treated set (<xref ref-type="fig" rid="F3">Fig. 3A</xref>; n=5 biological replicates per set). To further discriminate direct from indirect effects, we performed whole proteome on bead <italic>in vitro</italic> kinase assays (OBIKA) comparing the immobilized proteome of <italic>snf1</italic><sup><italic>as</italic></sup> cells growing exponentially in 5% Glucose in the presence of ATP analog, incubated with purified wild-type Snf1 to that incubated with a kinase-inactive Snf1<sup>T210A</sup> mutant (<xref ref-type="fig" rid="F3">Fig. 3A</xref>; n=5 biological replicates) (<xref ref-type="bibr" rid="R45">Hu <italic>et al</italic>., 2021</xref>).</p><p id="P9"><italic>In vivo</italic> analyses led to the identification of 40’547 phosphosites, of which 34’747 could be quantified (<xref ref-type="fig" rid="F3">Fig. 3B</xref>). After stringent filtering, we used 21’223 sites, which clearly localized to a specific amino acid residue (localization probability &gt;0.75) (<xref ref-type="bibr" rid="R77">Olsen et al., 2006</xref>) (<xref ref-type="supplementary-material" rid="SD2">Supplementary table S4A-B</xref>), for statistical analyses to identify potential Snf1 target sites. Class I target sites had to fulfill two criteria: sites had to be significantly upregulated (i) when using a random effect model comparing starved (5 min and 15 min) to non-starved cells (p&lt;0.05); and (ii) when comparing starved cells to cells treated additionally with the inhibitor 2NM-PP1 (t test, FDR&lt;0.05). Class II target sites had only to fulfill the second criterium. Class II sites contained target residues such as Ser<sup>1157</sup> in Acc1, the cytosolic acetyl-CoA carboxylase that is already phosphorylated by Snf1 in cells grown on 2% glucose, but dephosphorylated upon 2NM-PP1-mediated inhibition of Snf1<sup>as</sup> (<xref ref-type="bibr" rid="R13">Braun et al., 2014</xref>). In total, this led to a shortlist of 1’409 sites, divided into 984 class I sites and 425 class II sites (<xref ref-type="fig" rid="F3">Fig. 3B</xref> and <xref ref-type="supplementary-material" rid="SD2">Supplementary table S4C</xref>). Our shortlisted class I and class II sites cover between 26% and 53% of the previously published potential Snf1 target sites (<xref ref-type="bibr" rid="R13">Braun <italic>et al</italic>., 2014</xref>; <xref ref-type="bibr" rid="R52">Kanshin et al., 2017</xref>) (<xref ref-type="supplementary-material" rid="SD2">Supplementary table S4D</xref>), overlapping to a larger extent with the respective studies than the studies with each other (<xref ref-type="fig" rid="F3">Fig. 3C</xref>). In addition, we expand the potential Snf1 target repertoire by more than 1’200 sites highlighting the resource character of the current study. We performed hierarchically clustering to characterize the kinetic behavior of sites and observed five major clusters (<xref ref-type="fig" rid="F3">Fig. 3D</xref>): cluster <italic>a</italic> contains sites that responded fast and transiently after 5 min of stimulation; clusters <italic>b, c</italic>, and <italic>e</italic> contain sites that responded in a sustained manner after 5 min and 15 min; and cluster <italic>d</italic> contains late responders that reacted only after 15 min. Source proteins of cluster <italic>a</italic> relate to “regulation of growth”, amongst them the Snf1 target Mig1, while those in clusters <italic>b, c</italic>, and <italic>e</italic> are linked to “cell cycle, transcription, endocytosis, and proteins transport”, such as the zinc-finger and Snf1 target protein Msn4, and those in cluster <italic>d</italic> are enriched in “serine-threonine kinases”, like Snf1 and its interaction partners Atg1 and Sak1, as well as Sch9 (<xref ref-type="supplementary-material" rid="SD2">Supplementary table S4E</xref>).</p><p id="P10">To discriminate potential indirect effects observed <italic>in vivo</italic> from direct Snf1 targets, we overlaid the significantly regulated sites from the SILAC and OBIKA datasets. Of the 986 commonly identified and quantified sites, 145 sites on 98 source proteins were significantly regulated by both approaches, characterizing them as <italic>bona fide</italic> Snf1 target sites (<xref ref-type="fig" rid="F3">Fig. 3A</xref> and <xref ref-type="supplementary-material" rid="SD2">Supplementary table S4F</xref>). The consensus motif of these sites corroborates the published AMPK and Snf1 motif with two basic amino acid residues in the -3 and -4 positions and a hydrophobic leucine residue in the +4 position (<xref ref-type="fig" rid="F3">Fig. 3E</xref>) (<xref ref-type="bibr" rid="R23">Dale et al., 1995</xref>; <xref ref-type="bibr" rid="R37">Gwinn <italic>et al</italic>., 2008</xref>; <xref ref-type="bibr" rid="R96">Schaffer et al., 2015</xref>; <xref ref-type="bibr" rid="R97">Scott et al., 2002</xref>). As such, this further supports our interpretation that these sites are <italic>bona fide</italic> Snf1 target sites.</p><p id="P11">As a kinase generally regulates multiple proteins within a given pathway, we analyzed known protein-protein interactions of the 98 Snf1 target proteins in STRING DB, enabling us to generate a network of 57 proteins (<xref ref-type="fig" rid="F3">Fig. 3F</xref>) (<xref ref-type="bibr" rid="R105">Szklarczyk et al., 2021</xref>). In line with the significant overlap of our data with the ones published by Braun and colleagues (<xref ref-type="bibr" rid="R13">Braun <italic>et al</italic>., 2014</xref>), this network covers similar biological processes including intracellular trafficking, ribosome biogenesis, translation, mRNA metabolism, inositol phosphate metabolism, chromatin remodeling, and TORC1 signaling (<xref ref-type="fig" rid="F3">Fig. 3F</xref>). Gratifyingly, this network also includes most of the previously known proximal Snf1 targets including for instance Ccr4 (<xref ref-type="bibr" rid="R13">Braun <italic>et al</italic>., 2014</xref>), Cyr1/Cdc35 (<xref ref-type="bibr" rid="R74">Nicastro et al., 2015</xref>), Eap1 (<xref ref-type="bibr" rid="R13">Braun <italic>et al</italic>., 2014</xref>). Gat1 (<xref ref-type="bibr" rid="R55">Kulkarni et al., 2006</xref>), Gln3 (<xref ref-type="bibr" rid="R9">Bertram et al., 2002</xref>; <xref ref-type="bibr" rid="R55">Kulkarni <italic>et al</italic>., 2006</xref>), Mig1 (<xref ref-type="bibr" rid="R27">DeVit and Johnston, 1999</xref>; <xref ref-type="bibr" rid="R78">Ostling and Ronne, 1998</xref>; <xref ref-type="bibr" rid="R102">Smith et al., 1999</xref>; <xref ref-type="bibr" rid="R109">Treitel et al., 1998</xref>), Msn4 (<xref ref-type="bibr" rid="R31">Estruch and Carlson, 1993</xref>; <xref ref-type="bibr" rid="R84">Petrenko et al., 2013</xref>), and Rod1 (<xref ref-type="bibr" rid="R2">Alvaro et al., 2016</xref>; <xref ref-type="bibr" rid="R57">Laussel et al., 2022</xref>; <xref ref-type="bibr" rid="R76">O’Donnell and Schmidt, 2019</xref>; <xref ref-type="bibr" rid="R100">Shinoda and Kikuchi, 2007</xref>). In addition, the dataset also pinpoints potential Snf1 target residues in numerous proteins that have an assigned function as Snf1 effectors such as Aly2 and Bul2 (<xref ref-type="bibr" rid="R12">Bowman et al., 2022</xref>; <xref ref-type="bibr" rid="R76">O’Donnell and Schmidt, 2019</xref>; <xref ref-type="bibr" rid="R88">Ptacek et al., 2005</xref>), Glo3 (<xref ref-type="bibr" rid="R4">Arakel et al., 2019</xref>), Gpd2 (<xref ref-type="bibr" rid="R58">Lee et al., 2012</xref>), and Npr1 (<xref ref-type="bibr" rid="R14">Brito et al., 2019</xref>). Finally, Snf1-regulated residues were also identified in the Snf1-β-subunits Gal83 and Sip2 (<xref ref-type="bibr" rid="R16">Carling, 2004</xref>; <xref ref-type="bibr" rid="R41">Hedbacker and Carlson, 2008</xref>), the Sak1 kinase that phosphorylates Snf1-Thr<sup>210</sup> (<xref ref-type="bibr" rid="R35">González <italic>et al</italic>., 2020</xref>; <xref ref-type="bibr" rid="R41">Hedbacker and Carlson, 2008</xref>), the PP1 phosphatase Glc7-regulatory subunit Reg1 and the protein phosphatase C Ptc1 that share an overlapping role in the dephosphorylation of Snf1-pThr<sup>210</sup> (<xref ref-type="bibr" rid="R65">Ludin et al., 1998</xref>; <xref ref-type="bibr" rid="R68">McCartney and Schmidt, 2001</xref>; <xref ref-type="bibr" rid="R91">Ruiz et al., 2013</xref>), and Snf1 itself. These observations indicate that Snf1 is embedded and engaged in an elaborated feedback control network, which, based on our current data, can be experimentally addressed in the future.</p><p id="P12">As briefly mentioned above, our <italic>in vivo</italic> phosphoproteomic analyses also pinpointed several Snf1-regulated residues within proteins that act in the TORC1 signaling pathway, including Lst4 that functions upstream of TORC1, the TORC1 subunits Kog1 and Tco89, and the proximal TORC1 effector Sch9 (<xref ref-type="bibr" rid="R114">Urban <italic>et al</italic>., 2007</xref>) (<xref ref-type="fig" rid="F3">Fig. 3G</xref>). In addition, our analyses identified direct Snf1-target residues in Pib2, a phosphatidylinositol-3-phosphate (PI3P) and Kog1-binding protein that can both activate and inhibit TORC1 through its C-terminal and N-terminal domains, respectively (<xref ref-type="bibr" rid="R39">Hatakeyama, 2021</xref>; <xref ref-type="bibr" rid="R54">Kim and Cunningham, 2015</xref>; <xref ref-type="bibr" rid="R71">Michel et al., 2017</xref>; <xref ref-type="bibr" rid="R110">Troutman et al., 2022</xref>; <xref ref-type="bibr" rid="R115">Varlakhanova et al., 2017</xref>). Accordingly, Pib2 has been proposed to act, by still incompletely defined mechanisms, as a glutamine sensor that directly activates TORC1 (<xref ref-type="bibr" rid="R106">Tanigawa and Maeda, 2017</xref>; <xref ref-type="bibr" rid="R107">Tanigawa et al., 2021</xref>; <xref ref-type="bibr" rid="R113">Ukai et al., 2018</xref>), and to promote the formation of TORC1-bodies in long-term glucose-starved cells (<xref ref-type="bibr" rid="R104">Sullivan <italic>et al</italic>., 2019</xref>). From the 5 TORC1-related hits, we excluded Kog1 from further analyses because the potential Snf1 target residue in Kog1 that we identified was Ser<sup>491</sup>, and mutation of this residue has previously been found not to affect the capacity of glucose-starved cells to properly inactivate TORC1 within a short time frame (<xref ref-type="bibr" rid="R46">Hughes Hallett <italic>et al</italic>., 2015</xref>; <xref ref-type="bibr" rid="R104">Sullivan <italic>et al</italic>., 2019</xref>). We have also not given priority to the analysis of Tco89, since it is a heavily phosphorylated protein (&gt;70 phosphorylated residues) that we intend to dissect separately in parallel studies. Finally, we also did not follow up on the TORC1-stimulating protein Lst4. The reason for this is that loss of Lst4 did not significantly change the transient reactivation of TORC1 in glucose-starved, 2NM-PP1-treated <italic>snf1</italic><sup><italic>as</italic></sup> cells (<xref ref-type="supplementary-material" rid="SD1">Supplementary figure 2</xref>), even though it reduced the TORC1 activity in exponentially growing cells as reported (<xref ref-type="bibr" rid="R81">Péli-Gulli <italic>et al</italic>., 2015</xref>). Thus, we focused our subsequent experiments on the two remaining proteins, namely Pib2 and Sch9, and examined in more detail the consequences of their phosphorylation by Snf1 for signaling via the TORC1 pathway.</p></sec><sec id="S5"><title>Snf1 phosphorylates Pib2-Ser<sup>268,309</sup> to weaken its association with Kog1</title><p id="P13">Our phosphoproteomic approach identified 2 potential Snf1 target residues each within the Kog1-binding region of Pib2, Ser<sup>268</sup> and Ser<sup>309</sup>, of which the latter was also detected by OBIKA with Snf1 (<xref ref-type="fig" rid="F4">Fig. 4A-C</xref> and <xref ref-type="supplementary-material" rid="SD2">Supplementary tables S4C and S4F</xref>). To further corroborate these data, we carried out an <italic>in vitro</italic> Snf1 kinase assay using an N-terminally truncated Pib2 fragment as substrate, which, unlike full-length Pib2, could be stably expressed in and purified from bacteria. Accordingly, wild-type Snf1 (purified from yeast), but not the kinase-inactive Snf1<sup>T210A</sup>, was able to phosphorylate the Pib2 fragment. We also introduced mutations of Ser<sup>268</sup> and Ser<sup>309</sup> in the Pib2 fragment and replaced them with alanine (Ala) residues. The fragments carrying either one of these mutations were still phosphorylated by wild-type Snf1, though to a different extent, but when both mutations were combined, the phosphorylation level dropped significantly (<xref ref-type="fig" rid="F4">Fig. 4D</xref>). Together with our finding that the Snf1 complex was able to bind Pib2 in microscale thermophoresis assays (<xref ref-type="fig" rid="F4">Fig. 4E</xref>), our data therefore, led us to infer that Snf1 may control Pib2 function primarily through phosphorylation of the Ser<sup>268</sup> and Ser<sup>309</sup> residues.</p><p id="P14">To address the physiological role of Ser<sup>268/309</sup> phosphorylation in Pib2, we next studied the response to short-term glucose starvation of 2NM-PP1-treated and -untreated <italic>snf1</italic><sup><italic>as</italic></sup> strains that expressed either the phosphomutant Pib2<sup>S268A,S309A</sup> or the phosphomimetic Pib2<sup>S268E,S309E</sup>. The <italic>snf1</italic><sup><italic>as</italic></sup> strain in which <italic>PIB2</italic> was deleted served as control. Interestingly, expression of Pib2<sup>S268E,S309E</sup> or loss of Pib2, but not the expression of Pib2<sup>S268A,S309A</sup>, rendered TORC1 more sensitive to glucose-starvation in DMSO-treated control cells and largely suppressed the unscheduled reactivation of TORC1 in glucose starved cells in which Snf1<sup>as</sup> was inhibited by a 2NM-PP1-treatment (<xref ref-type="fig" rid="F4">Fig. 4F</xref> and <xref ref-type="fig" rid="F4">4G</xref>). These observations suggest that the TORC1 inactivation defect in Snf1-compromised cells is due to a defect in Pib2 phosphorylation. However, as a readout for TORC1 activity, we monitored the phosphorylation of the downstream effector kinase Sch9, which as mentioned above and further explained below, is itself a potential direct Snf1 substrate. Therefore, we sought to understand how Pib2 phosphorylation may affect TORC1 signaling. We noticed that the Ser<sup>268</sup> and Ser<sup>309</sup> Snf1 target sites reside within the Kog1-binding domains of Pib2 (<xref ref-type="bibr" rid="R71">Michel <italic>et al</italic>., 2017</xref>; <xref ref-type="bibr" rid="R104">Sullivan <italic>et al</italic>., 2019</xref>; <xref ref-type="bibr" rid="R110">Troutman <italic>et al</italic>., 2022</xref>), which led us to speculate that the phosphorylation state of these residues could affect the Pib2-Kog1 association. To this end, we performed co-immunoprecipitation assays and found that this was indeed the case, as we observed that the Pib2<sup>S268E,S309E</sup> variant exhibited significantly reduced affinity for Kog1 when compared to wild-type Pib2 or Pib2<sup>S268A,S309A</sup> (<xref ref-type="fig" rid="F4">Fig. 4H</xref>). Importantly, immunoblot analyses of the myc-tagged phosphomutant and phosphomimetic Pib2 variants showed that the introduction of the respective mutations in Pib2 did not affect the stability of the proteins (<xref ref-type="fig" rid="F4">Fig. 4I</xref>). Thus, the combined data led us to conclude that Snf1 activation in glucose-starved cells mediates TORC1 inhibition primarily through phosphorylation of Pib2 at Ser<sup>268/309</sup>, which serves to weaken the association between Pib2 and Kog1 and prevent it from activating TORC1 under these conditions.</p></sec><sec id="S6"><title>Snf1 constrains Sch9-Thr<sup>737</sup> phosphorylation by targeting Sch9-Ser<sup>288</sup></title><p id="P15">Our phosphoproteomic approach also identified one potential Snf1 target residue, namely Ser<sup>288</sup>, that lies within the C2 domain of Sch9 (<xref ref-type="fig" rid="F5">Fig. 5A</xref> and <xref ref-type="fig" rid="F5">5B</xref>, and <xref ref-type="supplementary-material" rid="SD2">Supplementary tables S4C and S4F</xref>). Like for Pib2, we tried to corroborate these data using <italic>in vitro</italic> Snf1 kinase assays and an N-terminal fragment of Sch9 as substrate, which, unlike full-length Sch9, could be stably expressed in and purified from bacteria. Here too, wild-type Snf1, but not the kinase-inactive Snf1<sup>T210A</sup> mutant, was able to phosphorylate this Sch9 fragment, and mutation of Ser<sup>288</sup> to alanine in the Sch9 fragment significantly reduced the phosphorylation level, indicating that this residue is likely the primary Snf1 target in the N-terminal part of Sch9 (<xref ref-type="fig" rid="F5">Fig. 5C</xref> and <xref ref-type="supplementary-material" rid="SD1">Supplementary figure 3</xref>). To further study the dynamics of Ser<sup>288</sup> phosphorylation <italic>in vivo</italic>, we raised antibodies that specifically recognize phosphorylated Ser<sup>288</sup> in Sch9 (Sch9-pSer<sup>288</sup>). Using these antibodies, we observed that the Sch9-pSer<sup>288</sup> levels were barely detectable in <italic>snf1</italic><sup><italic>as</italic></sup> cells growing exponentially on 2% glucose, but then rapidly and strongly increased in a Snf1-dependent manner following glucose starvation in DMSO-treated cells but not in 2NM-PP1 treated, Snf1-inhibited cells (<xref ref-type="fig" rid="F5">Fig. 5D</xref>; upper panels). In addition, the Sch9-pSer<sup>288</sup> levels were quite elevated in cells growing exponentially on very low glucose levels (<italic>i</italic>.<italic>e</italic>. 0.05%), but rapidly declined in cells where Snf1<sup>as</sup> was inactivated by 2NM-PP1 treatment (<xref ref-type="fig" rid="F5">Fig. 5D</xref>; lower panels). As expected, in control experiments performed with strains expressing Sch9<sup>S288A</sup> or Sch9<sup>S288E</sup> mutant versions, no Sch9-pSer<sup>288</sup> signal was detected (upper and lower panels). Together with our finding that the Snf1 complex was also able to bind the N-terminal Sch9 fragment in microscale thermophoresis assays (<xref ref-type="fig" rid="F5">Fig. 5E</xref>), our data therefore indicate that Ser<sup>288</sup> in Sch9 is a <italic>bona fide</italic> Snf1 target residue.</p><p id="P16">To address the physiological role of Ser<sup>288</sup> phosphorylation in Sch9, we next studied the relative TORC1 activity upon short-term glucose starvation in 2NM-PP1-treated and -untreated <italic>snf1</italic><sup><italic>as</italic></sup> strains that expressed either wild-type Sch9, the phosphomutant Sch9<sup>S288A</sup>, or the phosphomimetic Sch9<sup>S288E</sup> using Sch9-pThr<sup>737</sup> levels as a proxy. Interestingly, expression of Sch9<sup>S288E</sup>, but not expression of wild-type Sch9 or Sch9<sup>S288A</sup>, slightly but significantly suppressed the unscheduled reactivation of TORC1 in 2NM-PP1-treated Snf1<sup>as</sup>-inhibited glucose starved cells (<xref ref-type="fig" rid="F5">Fig. 5F</xref> and <xref ref-type="fig" rid="F5">5G</xref>). Thus, our data suggest that Snf1-mediated phosphorylation of Ser<sup>288</sup> negatively impacts on the capacity of TORC1 to phosphorylate the C-terminal Thr<sup>737</sup> in Sch9.</p></sec><sec id="S7"><title>Physiological effects of Sch9<sup>S288E</sup> and Pib2<sup>S268E,S309E</sup> are additive</title><p id="P17">Our data so far indicated that Snf1 controls TORC1 signaling both upstream (Pib2) and downstream (Sch9) of TORC1. To address the question of whether these effects are additive concerning the TORC1-controlled phosphorylation of Thr<sup>737</sup> in Sch9, we studied <italic>snf1</italic><sup><italic>as</italic></sup> strains in which the phosphomutant and phosphomimetic variants of Sch9 and Pib2 were expressed separately or combined. In line with our data above, the separate expression of Sch9<sup>S288E</sup> in Snf1<sup>as</sup>-inhibited (2NM-PP1-treated), glucose-starved cells only weakly suppressed the unscheduled reactivation of TORC1 (<italic>i</italic>.<italic>e</italic>. relative Sch9-Thr<sup>737</sup> phosphorylation), while this effect was already strong in the case of the separate expression of Pib2<sup>S268E,S309E</sup> and even stronger when the expression of Sch9<sup>S288E</sup> and Pib2<sup>S268E,S309E</sup> were combined (<xref ref-type="fig" rid="F6">Fig. 6A</xref> and <xref ref-type="fig" rid="F6">6B</xref>). In contrast, the separate and combined expression of Sch9<sup>S288A</sup> and Pib2<sup>S268A,S309A</sup> showed no significant effect in the same experiment. This led us to conclude that the effects of Snf1-mediated phosphorylation of Pib2 and Sch9 are additive with respect to the TORC1-mediated phosphorylation of Thr<sup>737</sup> in the Sch9 C-terminus. Further supporting this conclusion is the observation that only the combined expression of Pib2<sup>S268E,S309E</sup> and Sch9<sup>S288E</sup>, but not their individual expression, nor individual or combined expression of Pib2<sup>S268A,S309A</sup> and Sch9<sup>S288A</sup>, significantly reduced the relative Sch9-Thr<sup>737</sup> phosphorylation when cells were grown exponentially on low nitrogen-containing media where TORC1 activity is intrinsically low and Snf1 activity somewhat elevated (<xref ref-type="fig" rid="F6">Fig. 6C</xref> and <xref ref-type="fig" rid="F6">6D</xref>). Finally, cells expressing Pib2<sup>S268E,S309E</sup> and Sch9<sup>S288E</sup> combined were also more sensitive to sub-inhibitory concentrations of rapamycin than cells expressing only one of these alleles (<xref ref-type="fig" rid="F6">Fig. 6E</xref>). Thus, Snf1-mediated fine-tuning of TORC1 activity relies on the proper phosphorylation of both Pib2 and Sch9.</p></sec></sec><sec id="S8" sec-type="discussion"><title>Discussion</title><p id="P18">Snf1/AMPK and TORC1 are conserved central kinase modules of two opposing signaling pathways that control cell growth and metabolism in response to the availability of nutrients and energy. Accordingly, energy depletion activates Snf1/AMPK, which helps to maintain energy homeostasis by favoring catabolic and inhibiting anabolic processes that generate and consume ATP, respectively (<xref ref-type="bibr" rid="R38">Hardie et al., 2012</xref>). In contrast, intracellular nutrients and high energy levels activate TORC1, which favors anabolic processes such as lipid, nucleotide, and protein synthesis and inhibits the catabolic autophagic recycling of macromolecules (<xref ref-type="bibr" rid="R1">Albert and Hall, 2015</xref>; <xref ref-type="bibr" rid="R34">González and Hall, 2017</xref>; <xref ref-type="bibr" rid="R56">Laplante and Sabatini, 2012</xref>; <xref ref-type="bibr" rid="R60">Liu and Sabatini, 2020</xref>). Given the reciprocal cellular roles of Snf1/AMPK and TORC1, it is not surprising that their signaling pathways are wired to each other at different levels to coordinate the establishment of cellular homeostasis. TORC1, for instance, phosphorylates and thereby inhibits the catalytic subunit of AMPK in both mammals and the fission yeast <italic>Schizosaccharomyces pombe</italic> (<xref ref-type="bibr" rid="R59">Ling et al., 2020</xref>). Conversely, AMPK inhibits mTORC1 through phosphorylation of TSC2 and Raptor (<xref ref-type="bibr" rid="R37">Gwinn <italic>et al</italic>., 2008</xref>; <xref ref-type="bibr" rid="R48">Inoki <italic>et al</italic>., 2003b</xref>), while Snf1 contributes to TORC1-body formation through phosphorylation of Kog1 (<xref ref-type="bibr" rid="R46">Hughes Hallett <italic>et al</italic>., 2015</xref>; <xref ref-type="bibr" rid="R104">Sullivan <italic>et al</italic>., 2019</xref>). In this context, both our current and previous proteomics approaches identified several additional potential Snf1 target residues within TORC1 and some of its upstream regulators (<xref ref-type="bibr" rid="R13">Braun <italic>et al</italic>., 2014</xref>; <xref ref-type="bibr" rid="R52">Kanshin <italic>et al</italic>., 2017</xref>), which indicates that Snf1 may be more intimately linked to TORC1 than current knowledge suggests. Here we followed up on one of these leads, <italic>i</italic>.<italic>e</italic>. Pib2, and demonstrated that the Snf1-mediated phosphorylation of Pib2 is critical to inhibit TORC1 during the early phase of acute glucose starvation. Thus, our data extend the function of Pib2 to a hub that integrates both glutamine, as reported earlier (<xref ref-type="bibr" rid="R106">Tanigawa and Maeda, 2017</xref>; <xref ref-type="bibr" rid="R107">Tanigawa <italic>et al</italic>., 2021</xref>; <xref ref-type="bibr" rid="R113">Ukai <italic>et al</italic>., 2018</xref>), and glucose signals to control TORC1. Our current data favor a model according to which Snf1-mediated phosphorylation of the Kog1-binding domain in Pib2 weakens its affinity to Kog1 and thereby reduces the TORC1-activating influence of Pib2 that is mediated by the C-terminal TORC1-activating (CAD) domain via a mechanism that is still largely elusive. Interestingly, Pib2 has also been involved in the formation of TORC1 bodies, which seem not to be required for TORC1 inactivation <italic>per se</italic> but rather serve to increase the threshold for TORC1 reactivation after long-term glucose starvation (<xref ref-type="bibr" rid="R104">Sullivan <italic>et al</italic>., 2019</xref>). The latter process is primarily driven by phosphorylation of Kog1 and, albeit dependent on Pib2, may also require loosening of the Kog1-Pib2 association, because deletion of the N-terminal TORC1-inhibitory domain (NID) in Pib2 has been found to induce TORC1-body formation (<xref ref-type="bibr" rid="R104">Sullivan <italic>et al</italic>., 2019</xref>). Here too, the mechanistic details remain to be deciphered and will likely require detailed structural information on the interactions between Pib2, Kog1, and the EGOC that also plays a role in TORC1-body formation (<xref ref-type="bibr" rid="R104">Sullivan <italic>et al</italic>., 2019</xref>). Curiously, human phafin/LAPF, which is structurally most closely related to Pib2 and with which it shares the FYVE and CAD domains (<xref ref-type="bibr" rid="R54">Kim and Cunningham, 2015</xref>), also regulates mTORC1-controlled processes, but it remains currently unknown whether these effects are executed through regulation of mTORC1 (<xref ref-type="bibr" rid="R39">Hatakeyama, 2021</xref>).</p><p id="P19">The activities of the Snf1 and TORC1 pathways are also wired to each other through a set of directly or indirectly controlled common effectors that, given the opposite roles of Snf1 and TORC1 in cell metabolism, are generally inversely regulated by these pathways (<xref ref-type="bibr" rid="R24">De Virgilio, 2012</xref>). For instance, Snf1 and TORC1 converge on the transcription factor Gln3 and the eukaryotic translation initiation factor 2α (eIF2α) to oppositely regulate their function (<xref ref-type="bibr" rid="R8">Beck and Hall, 1999</xref>; <xref ref-type="bibr" rid="R9">Bertram <italic>et al</italic>., 2002</xref>; <xref ref-type="bibr" rid="R19">Cherkasova et al., 2010</xref>; <xref ref-type="bibr" rid="R20">Cherkasova and Hinnebusch, 2003</xref>). Interestingly, Snf1 and TORC1 have already previously been reported to directly converge on different residues within Sch9 (<xref ref-type="bibr" rid="R64">Lu et al., 2011</xref>), a key controller of protein synthesis and aging in yeast (<xref ref-type="bibr" rid="R61">Loewith and Hall, 2011</xref>). Accordingly, both kinases phosphorylate Sch9, but, while the TORC1 target residues in Sch9 have been functionally well-defined and located in the C-terminus of Sch9 (<xref ref-type="bibr" rid="R114">Urban <italic>et al</italic>., 2007</xref>), the respective Snf1 target residue(s) remained unidentified (<xref ref-type="bibr" rid="R64">Lu <italic>et al</italic>., 2011</xref>). Here, we show that Snf1 phosphorylates Ser<sup>288</sup> in Sch9, which is not only supported by our current and previous phosphoproteomic approaches (<xref ref-type="bibr" rid="R13">Braun <italic>et al</italic>., 2014</xref>), but also by our extended biochemical <italic>in vitro</italic> and <italic>in vivo</italic> studies of wild-type and Sch9<sup>S288A</sup> alleles. In line with the opposite conceptual roles of Snf1 and TORC1 within cells, our physiological experiments posit a model in which Snf1-mediated phosphorylation of Ser<sup>288</sup> in Sch9 antagonizes the TORC1-mediated phosphorylation (at Thr<sup>737</sup>) and hence activation of Sch9. Notably, such a model also provides an elegant explanation for the reciprocal role of Snf1 and Sch9 in controlling chronological life span (<xref ref-type="bibr" rid="R66">Maqani et al., 2018</xref>; <xref ref-type="bibr" rid="R117">Wei et al., 2008</xref>; <xref ref-type="bibr" rid="R118">Wierman et al., 2017</xref>), although it is difficult to reconcile with the idea that Snf1 activates Sch9 (in parallel to TORC1) to inhibit replicative lifespan (<xref ref-type="bibr" rid="R64">Lu <italic>et al</italic>., 2011</xref>). The latter assumption, however, appears to depend in part on the phosphorylation of a threonine(s) in Sch9, specifically in cells lacking the regulatory Snf1 subunit Sip2, and may therefore not be related to the Sch9-Ser<sup>288</sup> phosphorylation studied here. Of note, the question of how Ser<sup>288</sup> phosphorylation restrains TORC1-mediated phosphorylation of Sch9-Thr<sup>737</sup> also warrants further experimental efforts. The Ser<sup>288</sup> residue lies within the C2 domain that has been suggested to mediate the vacuolar recruitment of Sch9 (<xref ref-type="bibr" rid="R50">Jin et al., 2014</xref>). However, recent studies have elaborated that the membrane-localization of Sch9 is primarily defined by its N-terminal 184 amino acids, but not the C2 domain (<xref ref-type="bibr" rid="R18">Chen et al., 2021</xref>; <xref ref-type="bibr" rid="R75">Novarina et al., 2021</xref>). We therefore assume that the phosphorylation of Ser<sup>288</sup> within the C2 domain, rather than controlling the subcellular localization, may either interfere with appropriate TORC1 docking or favor the recruitment of a pThr<sup>737</sup>-targeting phosphatase to Sch9. As for Pib2, the resolution of these issues will likely require more detailed structural information on Sch9 that is currently not available.</p><p id="P20">In this study, we focused on the mechanisms through which Snf1 regulates TORC1 during the early phase of acute glucose starvation. Our phosphoproteome data, however, indicate that Snf1 may also control TORC1 through processes that are relevant during later phases of prolonged glucose starvation. For instance, we identified the lipid kinase Fab1, which generates phosphatidylinositol-3,5-bisphosphate (PI(3,5)P<sub>2</sub>) from PI3P, as a potential Snf1 target (<xref ref-type="fig" rid="F3">Fig. 3F</xref>). Fab1 is not only a TORC1 effector, but it also defines the activity and subcellular distribution (between vacuolar membranes and signaling endosomes) of TORC1 (<xref ref-type="bibr" rid="R18">Chen <italic>et al</italic>., 2021</xref>). Snf1 may therefore modulate the feedback control loop between Fab1 and TORC1 in response to glucose limitation. This function is likely executed by Snf1 complexes containing the β-subunit Sip1, which, in addition to being potentially feedback-controlled by Snf1, tethers Snf1 complexes to vacuolar membranes in response to carbon stress (<xref ref-type="bibr" rid="R42">Hedbacker et al., 2004</xref>). We also identified Snf1-regulated phospho-residues in Apl6, a subunit of the adaptor protein 3 (AP-3) complex that functions in cargo-selective protein transport from the TGN to the vacuole (Cowles et al., 1997). In this case, Snf1 may control the flux of Ego1 towards (and hence assembly of the TORC1-regulatory EGOC at) vacuolar membranes, which requires proper AP-3 function (<xref ref-type="bibr" rid="R40">Hatakeyama et al., 2019</xref>). Our mass spectrometry approaches further highlighted several phospho-residues in α-arrestins including Aly2, Bul1, and Bul2 that appeared to be regulated by Snf1. These arrestins drive Rsp5-mediated ubiquitination of specific nutrient transporters such as the amino acid permeases Gap1, Dip5, and others to orchestrate their endocytosis in response to nutrients (<xref ref-type="bibr" rid="R51">Kahlhofer et al., 2021</xref>; <xref ref-type="bibr" rid="R125">Zbieralski and Wawrzycka, 2022</xref>). Because amino acid permeases control TORC1 either via their role in distributing amino acids across cellular membrane compartments or through their proposed role as transceptors (<xref ref-type="bibr" rid="R69">Melick and Jewell, 2020</xref>; <xref ref-type="bibr" rid="R120">Wolfson and Sabatini, 2017</xref>; <xref ref-type="bibr" rid="R126">Zheng et al., 2016</xref>), it is conceivable that Snf1 also controls TORC1 indirectly via phosphorylation of α-arrestins. In a similar vein, Snf1 may also reduce ammonium uptake by impinging on the Npr1-regulated Par32, which inhibits the ammonium transporters Mep1 and Mep3 and thereby indirectly reduces TORC1 activity (<xref ref-type="bibr" rid="R11">Boeckstaens et al., 2015</xref>; <xref ref-type="bibr" rid="R116">Varlakhanova et al., 2018</xref>). Finally, two protein kinases, namely Ptk2 and Hkr1, which activate the plasma membrane H<sup>+</sup>-ATPase Pma1 in response to glucose (<xref ref-type="bibr" rid="R30">Eraso et al., 2006</xref>; <xref ref-type="bibr" rid="R36">Goossens et al., 2000</xref>), were also among the presumed Snf1 targets in our data set (<xref ref-type="fig" rid="F3">Fig. 3F</xref>). Through Ptk2 and Hkr1, Snf1 may conceivably adjust TORC1 activation that is related to Pma1 and H<sup>+</sup>-coupled nutrient uptake (<xref ref-type="bibr" rid="R92">Saliba et al., 2018</xref>). In sum, our proteomics study provides a wealth of new leads for future studies on how Snf1 may be wired to TORC1 to ensure cellular homeostasis under long-term glucose limitation.</p></sec><sec id="S9" sec-type="materials | methods"><title>Materials and methods</title><sec id="S10"><title>Yeast strains, plasmids, and growth conditions</title><p id="P21"><italic>Saccharomyces cerevisiae</italic> strains and plasmids are listed in <xref ref-type="supplementary-material" rid="SD2">Supplementary table 1 and Supplementary table 2</xref>. Point mutations were introduced in the genome by CRISPR-Cas9, as described (<xref ref-type="bibr" rid="R32">Generoso et al., 2016</xref>), while gene deletion and tagging were performed using the pFA6a system-based PCR-toolbox (<xref ref-type="bibr" rid="R49">Janke et al., 2004</xref>). The oligos used to generate the CRISPR/Cas9 plasmids are listed in <xref ref-type="supplementary-material" rid="SD2">Supplementary table 3</xref>. Plasmids were created as described earlier (<xref ref-type="bibr" rid="R32">Generoso <italic>et al</italic>., 2016</xref>). Strains were rendered prototrophic, unless stated otherwise, by transforming them with the empty centromeric plasmids listed in <xref ref-type="supplementary-material" rid="SD2">Supplementary table S2</xref>. In order to maintain the plasmids, cells were pregrown in a synthetic dropout (SD; 0.17% yeast nitrogen base, 0.5% ammonium sulfate [AS], 0.2% dropout mix [USBiological], and 2% glucose) medium. Then, synthetic complete medium (SC; SD with all amino acids) medium was used for the dilution of the cells the following day. The same procedure was adopted for experiments where cells were grown in media containing low glucose (<italic>i</italic>.<italic>e</italic>. 0.05% instead of 2% glucose) or low nitrogen (with a reduced amount of AS [0.0625%] and devoid of amino acids). Starvation experiments were performed by cell filtration and transfer to carbon starvation medium (SC without glucose) or nitrogen and carbon starvation medium (0.17% yeast nitrogen base), for the times indicated. For re-addition experiments, 2% final glucose and/or 3.3 mM glutamine was/were added to the culture. When indicated, 10 µM 2NM-PP1 dissolved in DMSO was added to the culture. As a control, the same volume of DMSO was added.</p></sec><sec id="S11"><title>Growth tests on plates</title><p id="P22">Cells were pregrown over-day in SD or SC until OD<sub>600nm</sub> above 1.0. Cells were washed two times with water and starting from the concentration of 1.0 OD<sub>600</sub>/mL, 10-fold serial dilutions were prepared in water. Cells were spotted on SD or SC plates with or without rapamycin, at the indicated concentrations, and further grown for 3 days at 30°C.</p></sec><sec id="S12"><title>SILAC conditions and cell lysis</title><p id="P23">Yeast strains were grown in synthetic dextrose complete medium containing either non-labeled or labeled lysine and arginine variants: “medium-heavy” L-arginine-<sup>13</sup>C<sub>6</sub> (Arg6) and L-lysine-<sup>2</sup>H<sub>4</sub> (Lys4), or “heavy” L-arginine-<sup>13</sup>C<sub>6</sub>-<sup>15</sup>N<sub>4</sub> (Arg10) and L-lysine-<sup>13</sup>C<sub>6</sub>-<sup>15</sup>N<sub>2</sub> (Lys8) amino acids (Sigma-Aldrich). Cells were grown in an SC medium supplemented with the appropriate lysine and arginine variants until reaching an OD<sub>600nm</sub> of approximatively 1.0. Then, cultures grown in the presence of “medium-heavy” and “heavy” arginine and lysine were filtered and resuspended in carbon starvation medium for 5 and 15 min, respectively, in the presence of the vehicle (DMSO) or 2NM-PP1. All cultures were ultimately collected by filtration. The nitrocellulose filter was dipped in tubes containing 40 mL of the cell culture medium plus TCA, 6% final concentration. Cells were pelleted and washed with 40 mL acetone and subsequently dried overnight in a freeze-dryer (ZIRBUS). Dried differentially labeled cells (30 mg) of each sample were mixed. Cells were lysed in 50 mL tubes with 6 mL urea buffer (8 M urea, 50 mM Tris HCl [pH 8.0]) and acid-washed glass beads using a Precellys machine (6 × 30 seconds, with 60 seconds pause after each cycle). Debris were pelleted and the supernatants containing cellular proteins were collected, followed by MS sample preparation.</p></sec><sec id="S13"><title>On beads <italic>in vitro</italic> kinase assay (OBIKA)</title><p id="P24">Cell pellets were obtained by five different cultures of <italic>snf1</italic><sup><italic>as</italic></sup> cells growing exponentially in 2 L 5% glucose YP (yeast extract-peptone). Cells were pre-grown overnight in YPD (YP-dextrose) and the following day, they were diluted at the concentration of 0.2 OD<sub>600</sub>/mL. Cells were grown until exponential phase, when they were treated with 10 µM 1NM-PP1 for 20 minutes. Cells were then collected by filtration, frozen in liquid nitrogen, and cryogenically disrupted by using a Precellys homogenizer in 10 mL of primary amine-free lysis buffer (50 mM HEPES pH 7.5, 1% NP-40, 150 mM NaCl, 1 mM EDTA pH 8.0, 1 mM EGTA pH 8.0 and Roche complete protease inhibitor EDTA-free) and acid-washed glass beads using a Precellys machine (6 × 30 seconds, with 60 seconds pause after each cycle). Lysates were collected by centrifugation at 4’000 rpm at 4°C. The lysates were dialyzed using dialysis buffer (50 mM HEPES pH 7.5, 0.1% NP-40, 150 mM NaCl, 1 mM EDTA pH 8.0, 1 mM EGTA pH 8.0, and 1 mM PMSF) and a molecular-porous membrane tubing (14 kDa, Sigma-Aldrich) to remove primary amine containing metabolites. After 2 h at 4°C, the buffer was refreshed for overnight dialysis. N-hydroxy-succinimide (NHS) -activated Sepharose beads (5 mL) were washed 3 times with 10 mL of ice-cold 1 mM HCl and 2 times with 10 mL of lysis buffer before incubating with 60 mg protein to saturate the beads. The coupling was performed on a rotating mixer at 4°C overnight. Next, the beads were spun down to remove the supernatant. Beads were then washed with 3 times with 10 mL of phosphatase buffer (50 mM HEPES, 100 mM NaCl, 0.1% NP-40). Phosphatase buffer (1 mL) containing 5’000 to 10’000 units of lambda phosphatase with 1 mM MnCl<sub>2</sub> was added and incubated for 4 h at room temperature or overnight at 4°C on a rotating mixer to dephosphorylate endogenous proteins. Beads were washed 2 times with 10 mL of kinase buffer (50 mM Tris-HCl pH 7.6, 10 mM MgCl<sub>2</sub>, 150 mM NaCl, and 1x PhosSTOP). Endogenous kinases bound to beads were inhibited by incubation with 1 mM FSBA in 1 mL of kinase buffer at RT on the rotor for 2 h. In addition, staurosporine was added to a final concentration of 100 µM to inhibit the remaining active kinases for 1 h. The beads were washed with 3 times with 10 mL of kinase buffer to remove non-bound kinase inhibitors. The supernatant was removed completely by gel loading tips. Kinase buffer was added to a volume of 860 µL for both kinase inactive and wild-type Snf1 samples. Subsequently, 100 µl of 10 mM ATP, 10 µL of 100 mM DTT, and 30 µl of purified kinase variants were added into each tube. Kinase assays were performed on a rotor at 37°C for 4 h. Finally, reactions were quenched by snap freezing in liquid nitrogen and samples were lyophilized overnight. Urea buffer (250 µL) was added to the dry beads, followed by MS sample preparation (<xref ref-type="bibr" rid="R45">Hu <italic>et al</italic>., 2021</xref>).</p></sec><sec id="S14"><title>MS sample preparation</title><p id="P25">For <italic>in vivo</italic> phosphoproteome and OBIKA samples, lysates or proteins on beads were reduced with 1 mM DTT, alkylated with 5 mM iodoacetamide, and digested with endoproteinase Lys-C for 4 h. The concentration of urea was diluted to 1 M before overnight trypsin digestion. The peptides were purified and fractionated as described previously (<xref ref-type="bibr" rid="R44">Hu et al., 2019</xref>). Briefly, peptides were purified by SPE using HR-X columns in combination with C18 cartridges. The purified peptides were frozen, lyophilized, and fractionated by HpH reversed-phase chromatography (<xref ref-type="bibr" rid="R7">Batth et al., 2014</xref>). A total of 96 fractions were mixed with an interval of 12 to yield 8 final fractions. The peptides were acidified, frozen in liquid nitrogen, and lyophilized before phosphopeptide enrichment.</p><p id="P26">For manual phosphopeptide enrichment, samples were incubated with 2 mg TiO<sub>2</sub> slurry, which was pre-incubated with 300 mg/mL lactic acid in 80% acetonitrile/1% trifluoroacetic acid (TFA) before enrichment for 30 min at room temperature (<xref ref-type="bibr" rid="R124">Zarei et al., 2016</xref>). For peptide elution, TiO<sub>2</sub> beads were transferred to 200 µL pipette tips, which were blocked by C8 discs. Tips were sequentially washed with 200 µL of 10% acetonitrile/1% TFA, twice with 200 µL of 80% acetonitrile/1% TFA, and 100 µL of LC-MS grade water. Phosphopeptides were eluted into single tubes with 50 µL of 1.25% ammonia in 20% acetonitrile and 50 µL of 1.25% ammonia in 80% acetonitrile. Eluates were acidified with 5 µL of formic acid. Samples were concentrated by vacuum concentration and resuspended in 20 µL of 0.1% formic acid for LC-MS/MS analysis. The tip flow-through was desalted by STAGE tips for non-phosphopeptide analysis.</p><p id="P27">Automated phosphopeptide enrichment was performed on an Automated Liquid Handling Platform (Bravo, Agilent) (<xref ref-type="bibr" rid="R85">Post et al., 2017</xref>). The Fe (III)-NTA cartridges (5 µL) were primed with 0.1% TFA in acetonitrile and equilibrated with 0.1% TFA in 80% acetonitrile (equilibration/washing buffer). Peptides were resuspended in 200 µL of equilibration buffer and loaded on the cartridges with a flow rate of 5 µL/min. Cartridges were washed twice with 200 µL of washing buffer with a flow rate of 10 µL/min. Phosphopeptides were eluted with 100 µL of 1% ammonia in 80% acetonitrile with a flow rate of 5 µL/min. Eluates were acidified with 5 µL of formic acid. Samples were concentrated by lyophilizer and resuspended in 20 µL of 0.1% formic acid for LC-MS/MS analysis.</p></sec><sec id="S15"><title>LC-MS/MS</title><p id="P28">LC-MS/MS measurements were performed on a QExactive (QE) Plus, HF-X, and Exploris480 mass spectrometer coupled to an EasyLC 1000 and EasyLC 1200 nanoflow-HPLC, respectively (all Thermo Scientific). Peptides were fractionated on a fused silica HPLC-column tip (I.D. 75 µm, New Objective, self-packed with ReproSil-Pur 120 C18-AQ, 1.9 µm (Dr. Maisch) to a length of 20 cm) using a gradient of A (0.1% formic acid in water) and B (0.1% formic acid in 80% acetonitrile in water): samples were loaded with 0% B with a max. pressure of 800 Bar; peptides were separated by 5%–30% B within 85 min with a flow rate of 250 nL/min. The spray voltage was set to 2.3 kV and the ion-transfer tube temperature to 250°C; no sheath and auxiliary gas were used. Mass spectrometers were operated in the data-dependent mode; after each MS scan (mass range m/z = 370 – 1750; resolution: 70’000 for QE Plus and 120’000 for HF-X and Exploris480) a maximum of ten scans for QE Plus, twelve scans HF-X and twenty scans for Exploris480 were performed using a normalized collision energy of 25%, a target value of 10’000 (QE Plus and HF-X)/5’000 (Exploris480) and a resolution of 17’500 for QE Plus, 30’000 for HF-X and 60’000 for Exploris480. MS raw files were analyzed using MaxQuant (version 1.6.2.10) (<xref ref-type="bibr" rid="R22">Cox and Mann, 2008</xref>) using a Uniprot full-length <italic>S. cerevisiae</italic> database plus common contaminants such as keratins and enzymes used for in-gel digestion as reference. Carbamidomethylcysteine was set as fixed modification and protein amino-terminal acetylation, serine-, threonine- and tyrosine- phosphorylation, and oxidation of methionine were set as variable modifications. The MS/MS tolerance was set to 20 ppm and three missed cleavages were allowed using trypsin/P as enzyme specificity. Peptide, site, and protein FDR based on a forward-reverse database were set to 0.01, the minimum peptide length was set to 7, the minimum score for modified peptides was 40, and the minimum number of peptides for identification of proteins was set to one, which must be unique. The “match-between-run” option was used with a time window of 0.7 min. MaxQuant results were analyzed using Perseus (<xref ref-type="bibr" rid="R112">Tyanova et al., 2016</xref>).</p></sec><sec id="S16"><title>MS data analyses</title><p id="P29">The <italic>in vivo</italic> phosphoproteome data were analyzed as described (<xref ref-type="bibr" rid="R44">Hu <italic>et al</italic>., 2019</xref>). Briefly, measurements of the log2 fold changes on each site were combined into a random effect model, considering a priori the sites as a random effect, and including the variability among replicates by also considering the replicates as a random effect. The model assigns an average effect size and its corresponding 95% confidence interval to each site. If the confidence interval includes values of zeros, then there is no statistically significant log2 fold change, whereas if the confidence interval is above (below) zero, there is statistical evidence for upregulation (downregulation). Additionally, imputation processes were applied on both protein and phosphosite levels. Proteins that were quantified in at least 2 biological replicates were kept and missing values were replaced by random values of a normal distribution to mimic low abundance measurements. Both width and down shift were applied according to Perseus default settings. Phosphosites were further normalized to the protein levels. Only sites which were quantified in at least 3 replicates in either DMSO 5 min or 15 min were kept. Missing values in 2NM-PP1-treated samples were then replaced by the maximum likelihood estimators (MLE) imputation method (<xref ref-type="bibr" rid="R70">Messer and Natarajan, 2008</xref>). Finally, a t-test (FDR ≤ 0.05) was performed between DMSO and 2NM-PP1-treated samples to determine significantly changing phosphosites.</p><p id="P30">OBIKA data were analyzed using Perseus. Phosphosites which were quantified in at least 3 replicates in WT samples were kept. Missing values in kinase-inactive samples were replaced by either random values of a normal distribution to mimic low abundance measurements, both width and down shift were applied according to default settings, when none of five replicates was quantified, or MLE, when at least 1 of five replicates was quantified. T-tests (FDR ≤ 0.05) were performed between WT and kinase-inactive samples to identify significantly changing sites.</p></sec><sec id="S17"><title>Protein purification and <italic>in vitro</italic> kinase assays</title><p id="P31">The Snf1 complex was purified from a Snf1-TEV-TAP-expressing yeast grown in YPD. To induce Snf1 activation, cells were washed on a filter. The same procedure was adopted to purify the catalytically inactive Snf1 complex containing the <italic>snf1</italic><sup><italic>T210A</italic></sup> α-subunit and the Snf1 complex, containing the C-terminally GFP-tagged Snf4 γ-subunit. Yeast cells carrying the plasmids for Sch9<sup>1-394</sup>-TEV-TAP or Sch9-TEV-TAP expression were grown overnight in SRafinose-Ura medium supplemented with 0.01% sucrose. The next day, in order to induce Sch9<sup>1-394</sup>-TEV-TAP and Sch9-TEV-TAP expression, 2% (final concentration) galactose was added to the cells when they reached OD<sub>600nm</sub> of 0.2. The induction with galactose was carried out for 6h.</p><p id="P32">For all the protein purification from yeast, cells were then collected by filtration, frozen in liquid nitrogen, and cryogenically disrupted by using a Precellys homogenizer in 10 mL of lysis buffer (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 0.1% NP-40, 10% glycerol, 400 mM Pefabloc, and Roche complete protease inhibitor EDTA-free). The cleared lysates were incubated for 2 h at 4°C with IgG-coupled Dynabeads (Dynabeads M-270 Epoxy; Invitrogen, Thermo Fisher Scientific, Basel, Switzerland). The beads were washes 5 times with lysis buffer and proteins were eluted in TEV buffer (50 mM Tris-HCl pH 7.5, 0.5 mM EDTA,) with 2% TEV protease and stored at -80°C after the addition of 10% glycerol.</p><p id="P33">Pib2 variants were purified from <italic>E. coli</italic> as described in (<xref ref-type="bibr" rid="R81">Péli-Gulli <italic>et al</italic>., 2015</xref>) using Ni-charged agarose beads (QIAGEN, product number 30210). Proteins were eluted in elution buffer (50 mM NaH<sub>2</sub>PO<sub>4</sub> pH 8.0, and 200 mM imidazole) and stored at -80°C after the addition of 10% glycerol.</p><p id="P34"><italic>In vitro</italic> radioactive kinase reactions were carried out in Snf1 kinase buffer (20 mM HEPES pH 7.5, 100 mM NaCl, 0.5 mM EDTA, 0.5 mM DTT, and 5 mM MgAc), with 60 ng Snf1 (quantified with respect to the Snf1 subunit), 1 µg Pib2, or 80 ng Sch9 in 20 µL total volume, and started by adding the ATP Mix (3 µL [γ-32P]-ATP [Hartmann Analytic, SRP-501], 6 µL 200 µM ATP, and 1µL Kinase Buffer 1X) and stopped by adding SDS-PAGE sample buffer. Reactions were carried out at 30°C and for 10 min or 30 min for Pib2 or Sch9, respectively. Proteins were separated by SDS-PAGE, stained with SYPRO Ruby (Sigma) to assess loading, and analysed using a phosphoimager (Typhoon FLA 9500; GE Healthcare). <italic>In vitro</italic> kinase assays probed by immunoblot analysis was carried out similarly as described above. The reaction was performed in 40 µL volume for 30 min at 30°C. In the ATP mix, [γ-<sup>32</sup>P]-ATP was substituted with H<sub>2</sub>O. Finally, the reaction was probed using the following antibodies: custom-made rabbit anti-Sch9-pSer<sup>288</sup> (Eurogentec, 1:4’000), and goat anti-Sch9 (GenScript, 1:1’000). To assess the loading, the gel was stained with SYPRO Ruby (Sigma).</p></sec><sec id="S18"><title>Co-immunoprecipitation</title><p id="P35">Yeast cells expressing the indicated fusion proteins were harvested by filtration, frozen in liquid nitrogen, and cryogenically disrupted using the Precellys homogenizer in 4 mL of lysis buffer (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 0.1% NP-40, 10% glycerol, 400 mM Pefabloc, and Roche complete protease inhibitor EDTA-free) with the addition of 60 mM glutamine as in (<xref ref-type="bibr" rid="R113">Ukai <italic>et al</italic>., 2018</xref>). Cleared lysates were equilibrated in the same lysis buffer. For input samples, aliquots of cleared lysates were collected and denatured in presence of SDS-PAGE sample buffer. For co-immunoprecipitations, the cleared lysates were incubated for 2 h at 4°C with prewashed anti-c-myc MagBeads (Pierce Thermo Fisher Scientific, product number 88843). After five washes with lysis buffer, beads were resuspended in 20 µL lysis buffer and denatured in presence of SDS-PAGE sample buffer. Inputs and pull-down samples were analyzed by SDS-PAGE immunoblot with mouse anti-myc (Santa Cruz, 1:10’000) and mouse anti-HA (ENZO, 1:1’000) antibodies.</p></sec><sec id="S19"><title>Microscale thermophoresis</title><p id="P36">Microscale thermophoresis (MST) experiments were performed using a Monolith NT.115 (Nanotemper Technologies). Labeled purified Snf1 complex (0.144 µM), containing the C-terminally GFP-tagged Snf4 γ-subunit, was mixed with a 2-fold serial dilution (a total of 16 samples) of unlabeled 18.1 µM Pib2<sup>221-635</sup> in elution buffer (50 mM NaH<sub>2</sub>PO<sub>4</sub> pH 8.0, 200 mM imidazole, and 10% glycerol) or with unlabeled 0.118 µM Sch9<sup>1-394</sup> in elution buffer (50 mM Tris-HCl pH 8.0, 0.5 mM EDTA, and 10% glycerol). Samples were loaded into Monolith NT.115 Capillaries and MST measurements were performed using 20% laser power setting at 30°C. Experiments were performed in triplicates and data were fitted using the <italic>K</italic><sub>d</sub> model of the MO.Affinity Analysis software (Nanotemper Technologies). The dissociation constant <italic>K</italic><sub>d</sub> was obtained by plotting the bound fraction against the logarithm of ligand concentration.</p></sec><sec id="S20"><title>Cell lysate preparation and immunoblot analyses</title><p id="P37">Cell lysates were prepared similarly as described in (<xref ref-type="bibr" rid="R40">Hatakeyama <italic>et al</italic>., 2019</xref>). After denaturation at 98°C for 5 minutes, samples were loaded on SDS-PAGE and transferred onto nitrocellulose membranes. After 1 h blocking with blocking buffer (5% milk powder in tris-buffered saline), membranes were immunoblotted with the following primary antibodies: rabbit anti-Adh1 (Calbiochem, product number 126745; 1:200’000 dilution), rabbit anti-Sch9-pThr<sup>737</sup> (De Virgilio lab, 1:10’000 dilution), rabbit anti-Sch9-pSer<sup>288</sup> (Rospert lab, 1:4’000 dilution), goat anti-Sch9 (De Virgilio lab, 1:1’000 dilution), rabbit anti-AMPK-pThr<sup>172</sup> (Cell Signal, product number 2535S, 1:1’000 dilution) to detect the phosphorylation of Snf1-Thr<sup>210</sup>, mouse anti-His<sub>6</sub> (Sigma, product number H1029, 1:1’000 dilution) to detect total levels of Snf1, anti-ACC1-pSer<sup>79</sup>(Thermo Fisher Scientific, product number PA5-17564, 1:500 dilution), and mouse anti-GFP (Roche, product number 11814460001, 1:3’000 dilution). After 3 washes, the membranes were incubated with anti-mouse (BIO-RAD, product number 170-6516; 1:3’000 dilution), rabbit (BIO-RAD, product number; 170-6515; 1:3’000 dilution), or goat (BIO-RAD, product number; 5160-2104; 1:3’000 dilution) secondary antibodies conjugated with horseradish peroxidase, washed again for 3 times, and developed with ECL (GE Healthcare).</p></sec><sec id="S21"><title>Statistical analyses</title><p id="P38">Statistical significance was determined by three or more independent biological replicates, by using Student’s t-test analysis, performed with GraphPad Prism 9.0. Unpaired Student’s t-test was used for the comparison of normalized data. Values with a p-value (or FDR where indicated) lower than 0.05 were considered significantly different. In the figure legends, the number of independent replicas, method used to express the variability, specific statistical tests, and significance are indicated.</p></sec></sec><sec sec-type="supplementary-material" id="SM"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="SD1"><label>Supplementary Figures</label><media xlink:href="EMS155982-supplement-Supplementary_Figures.pdf" mimetype="application" mime-subtype="pdf" id="d83aAdEbB" position="anchor"/></supplementary-material><supplementary-material content-type="local-data" id="SD2"><label>Supplementary Tables</label><media xlink:href="EMS155982-supplement-Supplementary_Tables.pdf" mimetype="application" mime-subtype="pdf" id="d83aAdEcB" position="anchor"/></supplementary-material></sec></body><back><ack id="S22"><title>Acknowledgments</title><p>We thank Riko Hatakeyama and Dieter Kressler for plasmids, Malika Jaquenoud for technical assistance, and Marie-Pierre Péli-Gulli for carefully reading the manuscript. This work was supported by the Canton of Fribourg (to J.D. and C.D.V.), the Swiss National Science Foundation (310030_166474/184671 to C.D.V. and 310030_184781 and 316030_177088 to J.D.), FWO-Vlaanderen (G069413, G0C7222N) and KU Leuven (C14/17/063, C14/21/095) to JW. We also acknowledge financial support from the Italian Ministry of University and Research (MUR) through grants 2020-ATE-0329 and “Dipartimenti di Eccellenza 2017” to the University of Milano-Bicocca, Department of Biotechnology and Biosciences (to F.T. and P.C.) and from the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) through Project-ID 403222702 - SFB 1381, TP B08 (to S.R.) and RO 1028/5-2 (to S.R.).</p></ack><sec id="S23" sec-type="data-availability"><title>Data availability</title><p id="P39">All data generated or analyzed during this study are included in the manuscript and supporting files. Source data files have been provided for <xref ref-type="fig" rid="F1">Figures 1</xref>-<xref ref-type="fig" rid="F6">6</xref> and <xref ref-type="supplementary-material" rid="SD1">Supplementary figures 1-3</xref>. The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium via the PRIDE partner repository with the dataset identifier PXD037381; username: <email>reviewer_pxd037381@ebi.ac.uk</email>, password: nCniJkTQ (Perez-Riverol et al., 2019).</p></sec><fn-group><fn id="FN1"><p id="P40"><bold>Additional Information</bold></p><p id="P41">Marco Caligaris: Conceptualization, Methodology, Validation, Formal analysis, Investigation,</p><p id="P42">Writing – review &amp; editing, Visualization.</p><p id="P43">Raffaele Nicastro: Conceptualization, Methodology, Validation, Formal analysis, Investigation,</p><p id="P44">Writing – review &amp; editing, Visualization, Supervision, Project administration.</p><p id="P45">Zehan Hu: Conceptualization, Methodology, Validation, Formal analysis, Investigation, Data curation, Writing – review &amp; editing, Visualization.</p><p id="P46">Farida Tripodi: Conceptualization, Validation, Writing – review &amp; editing.</p><p id="P47">Johannes Erwin Hummel: Methodology, Validation, Investigation, Writing – review &amp; editing.</p><p id="P48">Marie-Anne Deprez: Validation, Writing – review &amp; editing.</p><p id="P49">Joris Winderickx: Conceptualization, Validation, Writing – review &amp; editing.</p><p id="P50">Susanne Rospert: Conceptualization, Validation, Writing – review &amp; editing.</p><p id="P51">Paola Coccetti: Conceptualization, Validation, Writing – review &amp; editing.</p><p id="P52">Jörn Dengjel: Conceptualization, Methodology, Validation, Formal analysis, Resources, Writing – original draft, Writing – review &amp; editing, Visualization, Funding acquisition.</p><p id="P53">Claudio De Virgilio: Conceptualization, Methodology, Validation, Resources, Data curation, Writing original draft, Writing – review &amp; editing, Supervision, Project administration, Funding acquisition.</p></fn></fn-group><ref-list><ref id="R1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Albert</surname><given-names>V</given-names></name><name><surname>Hall</surname><given-names>MN</given-names></name></person-group><article-title>mTOR signaling in cellular and organismal energetics</article-title><source>Curr Opin Cell Biol</source><year>2015</year><volume>33</volume><fpage>55</fpage><lpage>66</lpage></element-citation></ref><ref id="R2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alvaro</surname><given-names>CG</given-names></name><name><surname>Aindow</surname><given-names>A</given-names></name><name><surname>Thorner</surname><given-names>J</given-names></name></person-group><article-title>Differential phosphorylation provides a switch to control how ⍺-arrestin Rod1 down-regulates mating pheromone response in Saccharomyces cerevisiae</article-title><source>Genetics</source><year>2016</year><volume>203</volume><fpage>299</fpage><lpage>317</lpage></element-citation></ref><ref id="R3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anandapadamanaban</surname><given-names>M</given-names></name><name><surname>Masson</surname><given-names>GR</given-names></name><name><surname>Perisic</surname><given-names>O</given-names></name><name><surname>Berndt</surname><given-names>A</given-names></name><name><surname>Kaufman</surname><given-names>J</given-names></name><name><surname>Johnson</surname><given-names>CM</given-names></name><name><surname>Santhanam</surname><given-names>B</given-names></name><name><surname>Rogala</surname><given-names>KB</given-names></name><name><surname>Sabatini</surname><given-names>DM</given-names></name><name><surname>Williams</surname><given-names>RL</given-names></name></person-group><article-title>Architecture of human Rag GTPase heterodimers and their complex with mTORC1</article-title><source>Science</source><year>2019</year><volume>366</volume><fpage>203</fpage><lpage>210</lpage></element-citation></ref><ref id="R4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arakel</surname><given-names>EC</given-names></name><name><surname>Huranova</surname><given-names>M</given-names></name><name><surname>Estrada</surname><given-names>AF</given-names></name><name><surname>Rau</surname><given-names>EM</given-names></name><name><surname>Spang</surname><given-names>A</given-names></name><name><surname>Schwappach</surname><given-names>B</given-names></name></person-group><article-title>Dissection of GTPase-activating proteins reveals functional asymmetry in the COPI coat of budding yeast</article-title><source>JCell Sci</source><year>2019</year><volume>132</volume><elocation-id>jcs232124</elocation-id></element-citation></ref><ref id="R5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bar-Peled</surname><given-names>L</given-names></name><name><surname>Chantranupong</surname><given-names>L</given-names></name><name><surname>Cherniack</surname><given-names>AD</given-names></name><name><surname>Chen</surname><given-names>WW</given-names></name><name><surname>Ottina</surname><given-names>KA</given-names></name><name><surname>Grabiner</surname><given-names>BC</given-names></name><name><surname>Spear</surname><given-names>ED</given-names></name><name><surname>Carter</surname><given-names>SL</given-names></name><name><surname>Meyerson</surname><given-names>M</given-names></name><name><surname>Sabatini</surname><given-names>DM</given-names></name></person-group><article-title>A Tumor suppressor complex with GAP activity for the Rag GTPases that signal amino acid sufficiency to mTORC1</article-title><source>Science</source><year>2013</year><volume>340</volume><fpage>1100</fpage><lpage>1106</lpage></element-citation></ref><ref id="R6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bar-Peled</surname><given-names>L</given-names></name><name><surname>Schweitzer</surname><given-names>LD</given-names></name><name><surname>Zoncu</surname><given-names>R</given-names></name><name><surname>Sabatini</surname><given-names>DM</given-names></name></person-group><article-title>Ragulator is a GEF for the Rag GTPases that signal amino acid levels to mTORC1</article-title><source>Cell</source><year>2012</year><volume>150</volume><fpage>1196</fpage><lpage>1208</lpage></element-citation></ref><ref id="R7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Batth</surname><given-names>TS</given-names></name><name><surname>Francavilla</surname><given-names>C</given-names></name><name><surname>Olsen</surname><given-names>JV</given-names></name></person-group><article-title>Off-line high-pH reversed-phase fractionation for in-depth phosphoproteomics</article-title><source>J Proteome Res</source><year>2014</year><volume>13</volume><fpage>6176</fpage><lpage>6186</lpage></element-citation></ref><ref id="R8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beck</surname><given-names>T</given-names></name><name><surname>Hall</surname><given-names>MN</given-names></name></person-group><article-title>The TOR signalling pathway controls nuclear localization of nutrient-regulated transcription factors</article-title><source>Nature</source><year>1999</year><volume>402</volume><fpage>689</fpage><lpage>692</lpage></element-citation></ref><ref id="R9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bertram</surname><given-names>PG</given-names></name><name><surname>Choi</surname><given-names>JH</given-names></name><name><surname>Carvalho</surname><given-names>J</given-names></name><name><surname>Chan</surname><given-names>TF</given-names></name><name><surname>Ai</surname><given-names>W</given-names></name><name><surname>Zheng</surname><given-names>XF</given-names></name></person-group><article-title>Convergence of TOR-nitrogen and Snf1-glucose signaling pathways onto Gln3</article-title><source>Mol Cell Biol</source><year>2002</year><volume>22</volume><fpage>1246</fpage><lpage>1252</lpage></element-citation></ref><ref id="R10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Binda</surname><given-names>M</given-names></name><name><surname>Péli-Gulli</surname><given-names>MP</given-names></name><name><surname>Bonfils</surname><given-names>G</given-names></name><name><surname>Panchaud</surname><given-names>N</given-names></name><name><surname>Urban</surname><given-names>J</given-names></name><name><surname>Sturgill</surname><given-names>TW</given-names></name><name><surname>Loewith</surname><given-names>R</given-names></name><name><surname>De Virgilio</surname><given-names>C</given-names></name></person-group><article-title>The Vam6 GEF controls TORC1 by activating the EGO complex</article-title><source>Mol Cell</source><year>2009</year><volume>35</volume><fpage>563</fpage><lpage>573</lpage></element-citation></ref><ref id="R11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boeckstaens</surname><given-names>M</given-names></name><name><surname>Merhi</surname><given-names>A</given-names></name><name><surname>Llinares</surname><given-names>E</given-names></name><name><surname>Van Vooren</surname><given-names>P</given-names></name><name><surname>Springael</surname><given-names>JY</given-names></name><name><surname>Wintjens</surname><given-names>R</given-names></name><name><surname>Marini</surname><given-names>AM</given-names></name></person-group><article-title>Identification of a novel regulatory mechanism of nutrient transport controlled by TORC1-Npr1-Amu1/Par32</article-title><source>PLoS Genet</source><year>2015</year><volume>11</volume><elocation-id>e1005382</elocation-id></element-citation></ref><ref id="R12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bowman</surname><given-names>RW</given-names><suffix>2nd</suffix></name><name><surname>Jordahl</surname><given-names>EM</given-names></name><name><surname>Davis</surname><given-names>S</given-names></name><name><surname>Hedayati</surname><given-names>S</given-names></name><name><surname>Barsouk</surname><given-names>H</given-names></name><name><surname>Ozbaki-Yagan</surname><given-names>N</given-names></name><name><surname>Chiang</surname><given-names>A</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>O’Donnell</surname><given-names>AF</given-names></name></person-group><article-title>TORC1 signaling controls the stability and function of ⍺-arrestins Aly1 and Aly2</article-title><source>Biomolecules</source><year>2022</year><volume>12</volume><fpage>533</fpage></element-citation></ref><ref id="R13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Braun</surname><given-names>KA</given-names></name><name><surname>Vaga</surname><given-names>S</given-names></name><name><surname>Dombek</surname><given-names>KM</given-names></name><name><surname>Fang</surname><given-names>F</given-names></name><name><surname>Palmisano</surname><given-names>S</given-names></name><name><surname>Aebersold</surname><given-names>R</given-names></name><name><surname>Young</surname><given-names>ET</given-names></name></person-group><article-title>Phosphoproteomic analysis identifies proteins involved in transcription-coupled mRNA decay as targets of Snf1 signaling</article-title><source>Sci Signal</source><year>2014</year><volume>7</volume><elocation-id>ra64</elocation-id></element-citation></ref><ref id="R14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brito</surname><given-names>AS</given-names></name><name><surname>Soto Diaz</surname><given-names>S</given-names></name><name><surname>Van Vooren</surname><given-names>P</given-names></name><name><surname>Godard</surname><given-names>P</given-names></name><name><surname>Marini</surname><given-names>AM</given-names></name><name><surname>Boeckstaens</surname><given-names>M</given-names></name></person-group><article-title>Pib2-dependent feedback control of the TORC1 signaling network by the Npr1 kinase</article-title><source>iScience</source><year>2019</year><volume>20</volume><fpage>415</fpage><lpage>433</lpage></element-citation></ref><ref id="R15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buerger</surname><given-names>C</given-names></name><name><surname>DeVries</surname><given-names>B</given-names></name><name><surname>Stambolic</surname><given-names>V</given-names></name></person-group><article-title>Localization of Rheb to the endomembrane is critical for its signaling function</article-title><source>Biochem Biophys Res Commun</source><year>2006</year><volume>344</volume><fpage>869</fpage><lpage>880</lpage></element-citation></ref><ref id="R16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carling</surname><given-names>D</given-names></name></person-group><article-title>The AMP-activated protein kinase cascade - a unifying system for energy control</article-title><source>Trends Biochem Sci</source><year>2004</year><volume>29</volume><fpage>18</fpage><lpage>24</lpage></element-citation></ref><ref id="R17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chandrashekarappa</surname><given-names>DG</given-names></name><name><surname>McCartney</surname><given-names>RR</given-names></name><name><surname>Schmidt</surname><given-names>MC</given-names></name></person-group><article-title>Ligand binding to the AMP-activated protein kinase active site mediates protection of the activation loop from dephosphorylation</article-title><source>J Biol Chem</source><year>2013</year><volume>288</volume><fpage>89</fpage><lpage>98</lpage></element-citation></ref><ref id="R18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Z</given-names></name><name><surname>Malia</surname><given-names>PC</given-names></name><name><surname>Hatakeyama</surname><given-names>R</given-names></name><name><surname>Nicastro</surname><given-names>R</given-names></name><name><surname>Hu</surname><given-names>Z</given-names></name><name><surname>Péli-Gulli</surname><given-names>MP</given-names></name><name><surname>Gao</surname><given-names>J</given-names></name><name><surname>Nishimura</surname><given-names>T</given-names></name><name><surname>Eskes</surname><given-names>E</given-names></name><name><surname>Stefan</surname><given-names>CJ</given-names></name><etal/></person-group><article-title>TORC1 determines Fab1 lipid kinase function at signaling endosomes and vacuoles</article-title><source>Curr Biol</source><year>2021</year><volume>31</volume><fpage>297</fpage><lpage>309</lpage><elocation-id>e298</elocation-id></element-citation></ref><ref id="R19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cherkasova</surname><given-names>V</given-names></name><name><surname>Qiu</surname><given-names>H</given-names></name><name><surname>Hinnebusch</surname><given-names>AG</given-names></name></person-group><article-title>Snf1 promotes phosphorylation of the ⍺ subunit of eukaryotic translation initiation factor 2 by activating Gcn2 and inhibiting phosphatases Glc7 and Sit4</article-title><source>Mol Cell Biol</source><year>2010</year><volume>30</volume><fpage>2862</fpage><lpage>2873</lpage></element-citation></ref><ref id="R20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cherkasova</surname><given-names>VA</given-names></name><name><surname>Hinnebusch</surname><given-names>AG</given-names></name></person-group><article-title>Translational control by TOR and TAP42 through dephosphorylation of eIF2⍺ kinase GCN2</article-title><source>Genes Dev</source><year>2003</year><volume>17</volume><fpage>859</fpage><lpage>872</lpage></element-citation></ref><ref id="R21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coccetti</surname><given-names>P</given-names></name><name><surname>Nicastro</surname><given-names>R</given-names></name><name><surname>Tripodi</surname><given-names>F</given-names></name></person-group><article-title>Conventional and emerging roles of the energy sensor Snf1/AMPK in Saccharomyces cerevisiae</article-title><source>Microb Cell</source><year>2018</year><volume>5</volume><fpage>482</fpage><lpage>494</lpage></element-citation></ref><ref id="R22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cox</surname><given-names>J</given-names></name><name><surname>Mann</surname><given-names>M</given-names></name></person-group><article-title>MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification</article-title><source>Nat Biotechnol</source><year>2008</year><volume>26</volume><fpage>1367</fpage><lpage>1372</lpage></element-citation></ref><ref id="R23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dale</surname><given-names>S</given-names></name><name><surname>Wilson</surname><given-names>WA</given-names></name><name><surname>Edelman</surname><given-names>AM</given-names></name><name><surname>Hardie</surname><given-names>DG</given-names></name></person-group><article-title>Similar substrate recognition motifs for mammalian AMP-activated protein kinase, higher plant HMG-CoA reductase kinase-A, yeast SNF1, and mammalian calmodulin-dependent protein kinase I</article-title><source>FEBS Lett</source><year>1995</year><volume>361</volume><fpage>191</fpage><lpage>195</lpage></element-citation></ref><ref id="R24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Virgilio</surname><given-names>C</given-names></name></person-group><article-title>The essence of yeast quiescence</article-title><source>FEMS Microbiol Rev</source><year>2012</year><volume>36</volume><fpage>306</fpage><lpage>339</lpage></element-citation></ref><ref id="R25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Demetriades</surname><given-names>C</given-names></name><name><surname>Doumpas</surname><given-names>N</given-names></name><name><surname>Teleman</surname><given-names>AA</given-names></name></person-group><article-title>Regulation of TORC1 in response to amino acid starvation via lysosomal recruitment of TSC2</article-title><source>Cell</source><year>2014</year><volume>156</volume><fpage>786</fpage><lpage>799</lpage></element-citation></ref><ref id="R26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deroover</surname><given-names>S</given-names></name><name><surname>Ghillebert</surname><given-names>R</given-names></name><name><surname>Broeckx</surname><given-names>T</given-names></name><name><surname>Winderickx</surname><given-names>J</given-names></name><name><surname>Rolland</surname><given-names>F</given-names></name></person-group><article-title>Trehalose-6-phosphate synthesis controls yeast gluconeogenesis downstream and independent of SNF1</article-title><source>FEMS Yeast Res</source><year>2016</year><volume>16</volume><elocation-id>fow036</elocation-id></element-citation></ref><ref id="R27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DeVit</surname><given-names>MJ</given-names></name><name><surname>Johnston</surname><given-names>M</given-names></name></person-group><article-title>The nuclear exportin Msn5 is required for nuclear export of the Mig1 glucose repressor of Saccharomyces cerevisiae</article-title><source>Curr Biol</source><year>1999</year><volume>9</volume><fpage>1231</fpage><lpage>1241</lpage></element-citation></ref><ref id="R28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dibble</surname><given-names>CC</given-names></name><name><surname>Elis</surname><given-names>W</given-names></name><name><surname>Menon</surname><given-names>S</given-names></name><name><surname>Qin</surname><given-names>W</given-names></name><name><surname>Klekota</surname><given-names>J</given-names></name><name><surname>Asara</surname><given-names>JM</given-names></name><name><surname>Finan</surname><given-names>PM</given-names></name><name><surname>Kwiatkowski</surname><given-names>DJ</given-names></name><name><surname>Murphy</surname><given-names>LO</given-names></name><name><surname>Manning</surname><given-names>BD</given-names></name></person-group><article-title>TBC1D7 is a third subunit of the TSC1-TSC2 complex upstream of mTORC1</article-title><source>Mol Cell</source><year>2012</year><volume>47</volume><fpage>535</fpage><lpage>546</lpage></element-citation></ref><ref id="R29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dubouloz</surname><given-names>F</given-names></name><name><surname>Deloche</surname><given-names>O</given-names></name><name><surname>Wanke</surname><given-names>V</given-names></name><name><surname>Cameroni</surname><given-names>E</given-names></name><name><surname>De Virgilio</surname><given-names>C</given-names></name></person-group><article-title>The TOR and EGO protein complexes orchestrate microautophagy in yeast</article-title><source>Mol Cell</source><year>2005</year><volume>19</volume><fpage>15</fpage><lpage>26</lpage></element-citation></ref><ref id="R30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eraso</surname><given-names>P</given-names></name><name><surname>Mazon</surname><given-names>MJ</given-names></name><name><surname>Portillo</surname><given-names>F</given-names></name></person-group><article-title>Yeast protein kinase Ptk2 localizes at the plasma membrane and phosphorylates in vitro the C-terminal peptide of the H<sup>+</sup>-ATPase</article-title><source>Biochim Biophys Acta</source><year>2006</year><volume>1758</volume><fpage>164</fpage><lpage>170</lpage></element-citation></ref><ref id="R31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Estruch</surname><given-names>F</given-names></name><name><surname>Carlson</surname><given-names>M</given-names></name></person-group><article-title>Two homologous zinc finger genes identified by multicopy suppression in a SNF1 protein kinase mutant of Saccharomyces cerevisiae</article-title><source>Mol Cell Biol</source><year>1993</year><volume>13</volume><fpage>3872</fpage><lpage>3881</lpage></element-citation></ref><ref id="R32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Generoso</surname><given-names>WC</given-names></name><name><surname>Gottardi</surname><given-names>M</given-names></name><name><surname>Oreb</surname><given-names>M</given-names></name><name><surname>Boles</surname><given-names>E</given-names></name></person-group><article-title>Simplified CRISPR-Cas genome editing for Saccharomyces cerevisiae</article-title><source>J Microbiol Methods</source><year>2016</year><volume>127</volume><fpage>203</fpage><lpage>205</lpage></element-citation></ref><ref id="R33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghillebert</surname><given-names>R</given-names></name><name><surname>Swinnen</surname><given-names>E</given-names></name><name><surname>Wen</surname><given-names>J</given-names></name><name><surname>Vandesteene</surname><given-names>L</given-names></name><name><surname>Ramon</surname><given-names>M</given-names></name><name><surname>Norga</surname><given-names>K</given-names></name><name><surname>Rolland</surname><given-names>F</given-names></name><name><surname>Winderickx</surname><given-names>J</given-names></name></person-group><article-title>The AMPK/SNF1/SnRK1 fuel gauge and energy regulator: structure, function and regulation</article-title><source>FEBS J</source><year>2011</year><volume>278</volume><fpage>3978</fpage><lpage>3990</lpage></element-citation></ref><ref id="R34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>González</surname><given-names>A</given-names></name><name><surname>Hall</surname><given-names>MN</given-names></name></person-group><article-title>Nutrient sensing and TOR signaling in yeast and mammals</article-title><source>EMBO J</source><year>2017</year><volume>36</volume><fpage>397</fpage><lpage>408</lpage></element-citation></ref><ref id="R35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>González</surname><given-names>A</given-names></name><name><surname>Hall</surname><given-names>MN</given-names></name><name><surname>Lin</surname><given-names>SC</given-names></name><name><surname>Hardie</surname><given-names>DG</given-names></name></person-group><article-title>AMPK and TOR: The Yin and Yang of Cellular Nutrient Sensing and Growth Control</article-title><source>Cell Metab</source><year>2020</year><volume>31</volume><fpage>472</fpage><lpage>492</lpage></element-citation></ref><ref id="R36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goossens</surname><given-names>A</given-names></name><name><surname>de La Fuente</surname><given-names>N</given-names></name><name><surname>Forment</surname><given-names>J</given-names></name><name><surname>Serrano</surname><given-names>R</given-names></name><name><surname>Portillo</surname><given-names>F</given-names></name></person-group><article-title>Regulation of yeast H<sup>+</sup>-ATPase by protein kinases belonging to a family dedicated to activation of plasma membrane transporters</article-title><source>Mol Cell Biol</source><year>2000</year><volume>20</volume><fpage>7654</fpage><lpage>7661</lpage></element-citation></ref><ref id="R37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gwinn</surname><given-names>DM</given-names></name><name><surname>Shackelford</surname><given-names>DB</given-names></name><name><surname>Egan</surname><given-names>DF</given-names></name><name><surname>Mihaylova</surname><given-names>MM</given-names></name><name><surname>Mery</surname><given-names>A</given-names></name><name><surname>Vasquez</surname><given-names>DS</given-names></name><name><surname>Turk</surname><given-names>BE</given-names></name><name><surname>Shaw</surname><given-names>RJ</given-names></name></person-group><article-title>AMPK phosphorylation of raptor mediates a metabolic checkpoint</article-title><source>Mol Cell</source><year>2008</year><volume>30</volume><fpage>214</fpage><lpage>226</lpage></element-citation></ref><ref id="R38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hardie</surname><given-names>DG</given-names></name><name><surname>Ross</surname><given-names>FA</given-names></name><name><surname>Hawley</surname><given-names>SA</given-names></name></person-group><article-title>AMPK: a nutrient and energy sensor that maintains energy homeostasis</article-title><source>Nat Rev Mol Cell Biol</source><year>2012</year><volume>13</volume><fpage>251</fpage><lpage>262</lpage></element-citation></ref><ref id="R39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hatakeyama</surname><given-names>R</given-names></name></person-group><article-title>Pib2 as an Emerging Master Regulator of Yeast TORC1</article-title><source>Biomolecules</source><year>2021</year><volume>11</volume><fpage>1489</fpage></element-citation></ref><ref id="R40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hatakeyama</surname><given-names>R</given-names></name><name><surname>Péli-Gulli</surname><given-names>MP</given-names></name><name><surname>Hu</surname><given-names>Z</given-names></name><name><surname>Jaquenoud</surname><given-names>M</given-names></name><name><surname>Garcia Osuna</surname><given-names>GM</given-names></name><name><surname>Sardu</surname><given-names>A</given-names></name><name><surname>Dengjel</surname><given-names>J</given-names></name><name><surname>De Virgilio</surname><given-names>C</given-names></name></person-group><article-title>Spatially distinct pools of TORC1 balance protein homeostasis</article-title><source>Mol Cell</source><year>2019</year><volume>73</volume><fpage>325</fpage><lpage>338</lpage><elocation-id>e328</elocation-id></element-citation></ref><ref id="R41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hedbacker</surname><given-names>K</given-names></name><name><surname>Carlson</surname><given-names>M</given-names></name></person-group><article-title>SNF1/AMPK pathways in yeast</article-title><source>Front Biosci</source><year>2008</year><volume>13</volume><fpage>2408</fpage><lpage>2420</lpage></element-citation></ref><ref id="R42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hedbacker</surname><given-names>K</given-names></name><name><surname>Townley</surname><given-names>R</given-names></name><name><surname>Carlson</surname><given-names>M</given-names></name></person-group><article-title>Cyclic AMP-dependent protein kinase regulates the subcellular localization of Snf1-Sip1 protein kinase</article-title><source>Mol Cell Biol</source><year>2004</year><volume>24</volume><fpage>1836</fpage><lpage>1843</lpage></element-citation></ref><ref id="R43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Herzig</surname><given-names>S</given-names></name><name><surname>Shaw</surname><given-names>RJ</given-names></name></person-group><article-title>AMPK: guardian of metabolism and mitochondrial homeostasis</article-title><source>Nat Rev Mol Cell Biol</source><year>2018</year><volume>19</volume><fpage>121</fpage><lpage>135</lpage></element-citation></ref><ref id="R44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>Z</given-names></name><name><surname>Raucci</surname><given-names>S</given-names></name><name><surname>Jaquenoud</surname><given-names>M</given-names></name><name><surname>Hatakeyama</surname><given-names>R</given-names></name><name><surname>Stumpe</surname><given-names>M</given-names></name><name><surname>Rohr</surname><given-names>R</given-names></name><name><surname>Reggiori</surname><given-names>F</given-names></name><name><surname>De Virgilio</surname><given-names>C</given-names></name><name><surname>Dengjel</surname><given-names>J</given-names></name></person-group><article-title>Multilayered control of protein turnover by TORC1 and Atg1</article-title><source>Cell Rep</source><year>2019</year><volume>28</volume><fpage>3486</fpage><lpage>3496</lpage></element-citation></ref><ref id="R45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>Z</given-names></name><name><surname>Sankar</surname><given-names>DS</given-names></name><name><surname>Vu</surname><given-names>B</given-names></name><name><surname>Leytens</surname><given-names>A</given-names></name><name><surname>Vionnet</surname><given-names>C</given-names></name><name><surname>Wu</surname><given-names>W</given-names></name><name><surname>Stumpe</surname><given-names>M</given-names></name><name><surname>Martínez-Martínez</surname><given-names>E</given-names></name><name><surname>Stork</surname><given-names>B</given-names></name><name><surname>Dengjel</surname><given-names>J</given-names></name></person-group><article-title>ULK1 phosphorylation of striatin activates protein phosphatase 2A and autophagy</article-title><source>Cell Rep</source><year>2021</year><volume>36</volume><elocation-id>109762</elocation-id></element-citation></ref><ref id="R46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hughes Hallett</surname><given-names>JE</given-names></name><name><surname>Luo</surname><given-names>X</given-names></name><name><surname>Capaldi</surname><given-names>AP</given-names></name></person-group><article-title>Snf1/AMPK promotes the formation of Kog1/Raptor-bodies to increase the activation threshold of TORC1 in budding yeast</article-title><source>eLife</source><year>2015</year><volume>4</volume><elocation-id>e09181</elocation-id></element-citation></ref><ref id="R47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Inoki</surname><given-names>K</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Xu</surname><given-names>T</given-names></name><name><surname>Guan</surname><given-names>KL</given-names></name></person-group><article-title>Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling</article-title><source>Genes Dev</source><year>2003a</year><volume>17</volume><fpage>1829</fpage><lpage>1834</lpage></element-citation></ref><ref id="R48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Inoki</surname><given-names>K</given-names></name><name><surname>Zhu</surname><given-names>T</given-names></name><name><surname>Guan</surname><given-names>KL</given-names></name></person-group><article-title>TSC2 mediates cellular energy response to control cell growth and survival</article-title><source>Cell</source><year>2003b</year><volume>115</volume><fpage>577</fpage><lpage>590</lpage></element-citation></ref><ref id="R49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Janke</surname><given-names>C</given-names></name><name><surname>Magiera</surname><given-names>MM</given-names></name><name><surname>Rathfelder</surname><given-names>N</given-names></name><name><surname>Taxis</surname><given-names>C</given-names></name><name><surname>Reber</surname><given-names>S</given-names></name><name><surname>Maekawa</surname><given-names>H</given-names></name><name><surname>Moreno-Borchart</surname><given-names>A</given-names></name><name><surname>Doenges</surname><given-names>G</given-names></name><name><surname>Schwob</surname><given-names>E</given-names></name><name><surname>Schiebel</surname><given-names>E</given-names></name><name><surname>Knop</surname><given-names>M</given-names></name></person-group><article-title>A versatile toolbox for PCR-based tagging of yeast genes: new fluorescent proteins, more markers and promoter substitution cassettes</article-title><source>Yeast</source><year>2004</year><volume>21</volume><fpage>947</fpage><lpage>962</lpage></element-citation></ref><ref id="R50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jin</surname><given-names>N</given-names></name><name><surname>Mao</surname><given-names>K</given-names></name><name><surname>Jin</surname><given-names>Y</given-names></name><name><surname>Tevzadze</surname><given-names>G</given-names></name><name><surname>Kauffman</surname><given-names>EJ</given-names></name><name><surname>Park</surname><given-names>S</given-names></name><name><surname>Bridges</surname><given-names>D</given-names></name><name><surname>Loewith</surname><given-names>R</given-names></name><name><surname>Saltiel</surname><given-names>AR</given-names></name><name><surname>Klionsky</surname><given-names>DJ</given-names></name><name><surname>Weisman</surname><given-names>LS</given-names></name></person-group><article-title>Roles for PI(3,5)P<sub>2</sub> in nutrient sensing through TORC1</article-title><source>Mol Biol Cell</source><year>2014</year><volume>25</volume><fpage>1171</fpage><lpage>1185</lpage></element-citation></ref><ref id="R51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kahlhofer</surname><given-names>J</given-names></name><name><surname>Leon</surname><given-names>S</given-names></name><name><surname>Teis</surname><given-names>D</given-names></name><name><surname>Schmidt</surname><given-names>O</given-names></name></person-group><article-title>The ⍺-arrestin family of ubiquitin ligase adaptors links metabolism with selective endocytosis</article-title><source>Biol Cell</source><year>2021</year><volume>113</volume><fpage>183</fpage><lpage>219</lpage></element-citation></ref><ref id="R52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kanshin</surname><given-names>E</given-names></name><name><surname>Giguere</surname><given-names>S</given-names></name><name><surname>Jing</surname><given-names>C</given-names></name><name><surname>Tyers</surname><given-names>M</given-names></name><name><surname>Thibault</surname><given-names>P</given-names></name></person-group><article-title>Machine learning of global phosphoproteomic profiles enables discrimination of direct versus indirect kinase substrates</article-title><source>Mol Cell Proteomics</source><year>2017</year><volume>16</volume><fpage>786</fpage><lpage>798</lpage></element-citation></ref><ref id="R53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kawai</surname><given-names>S</given-names></name><name><surname>Urban</surname><given-names>J</given-names></name><name><surname>Piccolis</surname><given-names>M</given-names></name><name><surname>Panchaud</surname><given-names>N</given-names></name><name><surname>De Virgilio</surname><given-names>C</given-names></name><name><surname>Loewith</surname><given-names>R</given-names></name></person-group><article-title>Mitochondrial genomic dysfunction causes dephosphorylation of Sch9 in the yeast Saccharomyces cerevisiae</article-title><source>Eukaryot Cell</source><year>2011</year><volume>10</volume><fpage>1367</fpage><lpage>1369</lpage></element-citation></ref><ref id="R54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>A</given-names></name><name><surname>Cunningham</surname><given-names>KW</given-names></name></person-group><article-title>A LAPF/phafin1-like protein regulates TORC1 and lysosomal membrane permeabilization in response to endoplasmic reticulum membrane stress</article-title><source>Mol Biol Cell</source><year>2015</year><volume>26</volume><fpage>4631</fpage><lpage>4645</lpage></element-citation></ref><ref id="R55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kulkarni</surname><given-names>A</given-names></name><name><surname>Buford</surname><given-names>TD</given-names></name><name><surname>Rai</surname><given-names>R</given-names></name><name><surname>Cooper</surname><given-names>TG</given-names></name></person-group><article-title>Differing responses of Gat1 and Gln3 phosphorylation and localization to rapamycin and methionine sulfoximine treatment in Saccharomyces cerevisiae</article-title><source>FEMS Yeast Res</source><year>2006</year><volume>6</volume><fpage>218</fpage><lpage>229</lpage></element-citation></ref><ref id="R56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laplante</surname><given-names>M</given-names></name><name><surname>Sabatini</surname><given-names>DM</given-names></name></person-group><article-title>mTOR signaling in growth control and disease</article-title><source>Cell</source><year>2012</year><volume>149</volume><fpage>274</fpage><lpage>293</lpage></element-citation></ref><ref id="R57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laussel</surname><given-names>C</given-names></name><name><surname>Albanèse</surname><given-names>V</given-names></name><name><surname>García-Rodríguez</surname><given-names>FJ</given-names></name><name><surname>Ballin</surname><given-names>A</given-names></name><name><surname>Defenouillère</surname><given-names>Q</given-names></name><name><surname>Léon</surname><given-names>S</given-names></name></person-group><article-title>2-deoxyglucose transiently inhibits yeast AMPK signaling and triggers glucose transporter endocytosis, potentiating the drug toxicity</article-title><source>PLoS Genet</source><year>2022</year><volume>18</volume><elocation-id>e1010169</elocation-id></element-citation></ref><ref id="R58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>YJ</given-names></name><name><surname>Jeschke</surname><given-names>GR</given-names></name><name><surname>Roelants</surname><given-names>FM</given-names></name><name><surname>Thorner</surname><given-names>J</given-names></name><name><surname>Turk</surname><given-names>BE</given-names></name></person-group><article-title>Reciprocal phosphorylation of yeast glycerol-3-phosphate dehydrogenases in adaptation to distinct types of stress</article-title><source>Mol Cell Biol</source><year>2012</year><volume>32</volume><fpage>4705</fpage><lpage>4717</lpage></element-citation></ref><ref id="R59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ling</surname><given-names>NXY</given-names></name><name><surname>Kaczmarek</surname><given-names>A</given-names></name><name><surname>Hoque</surname><given-names>A</given-names></name><name><surname>Davie</surname><given-names>E</given-names></name><name><surname>Ngoei</surname><given-names>KRW</given-names></name><name><surname>Morrison</surname><given-names>KR</given-names></name><name><surname>Smiles</surname><given-names>WJ</given-names></name><name><surname>Forte</surname><given-names>GM</given-names></name><name><surname>Wang</surname><given-names>T</given-names></name><name><surname>Lie</surname><given-names>S</given-names></name><etal/></person-group><article-title>mTORC1 directly inhibits AMPK to promote cell proliferation under nutrient stress</article-title><source>Nat Metab</source><year>2020</year><volume>2</volume><fpage>41</fpage><lpage>49</lpage></element-citation></ref><ref id="R60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>GY</given-names></name><name><surname>Sabatini</surname><given-names>DM</given-names></name></person-group><article-title>mTOR at the nexus of nutrition, growth, ageing and disease</article-title><source>Nat Rev Mol Cell Biol</source><year>2020</year><volume>21</volume><fpage>183</fpage><lpage>203</lpage></element-citation></ref><ref id="R61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Loewith</surname><given-names>R</given-names></name><name><surname>Hall</surname><given-names>MN</given-names></name></person-group><article-title>Target of rapamycin (TOR) in nutrient signaling and growth control</article-title><source>Genetics</source><year>2011</year><volume>189</volume><fpage>1177</fpage><lpage>1201</lpage></element-citation></ref><ref id="R62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Loewith</surname><given-names>R</given-names></name><name><surname>Jacinto</surname><given-names>E</given-names></name><name><surname>Wullschleger</surname><given-names>S</given-names></name><name><surname>Lorberg</surname><given-names>A</given-names></name><name><surname>Crespo</surname><given-names>JL</given-names></name><name><surname>Bonenfant</surname><given-names>D</given-names></name><name><surname>Oppliger</surname><given-names>W</given-names></name><name><surname>Jenoe</surname><given-names>P</given-names></name><name><surname>Hall</surname><given-names>MN</given-names></name></person-group><article-title>Two TOR complexes, only one of which is rapamycin sensitive, have distinct roles in cell growth control</article-title><source>Mol Cell</source><year>2002</year><volume>10</volume><fpage>457</fpage><lpage>468</lpage></element-citation></ref><ref id="R63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Long</surname><given-names>X</given-names></name><name><surname>Lin</surname><given-names>Y</given-names></name><name><surname>Ortiz-Vega</surname><given-names>S</given-names></name><name><surname>Yonezawa</surname><given-names>K</given-names></name><name><surname>Avruch</surname><given-names>J</given-names></name></person-group><article-title>Rheb binds and regulates the mTOR kinase</article-title><source>Curr Biol</source><year>2005</year><volume>15</volume><fpage>702</fpage><lpage>713</lpage></element-citation></ref><ref id="R64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>JY</given-names></name><name><surname>Lin</surname><given-names>YY</given-names></name><name><surname>Sheu</surname><given-names>JC</given-names></name><name><surname>Wu</surname><given-names>JT</given-names></name><name><surname>Lee</surname><given-names>FJ</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Lin</surname><given-names>MI</given-names></name><name><surname>Chiang</surname><given-names>FT</given-names></name><name><surname>Tai</surname><given-names>TY</given-names></name><name><surname>Berger</surname><given-names>SL</given-names></name><etal/></person-group><article-title>Acetylation of yeast AMPK controls intrinsic aging independently of caloric restriction</article-title><source>Cell</source><year>2011</year><volume>146</volume><fpage>969</fpage><lpage>979</lpage></element-citation></ref><ref id="R65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ludin</surname><given-names>K</given-names></name><name><surname>Jiang</surname><given-names>R</given-names></name><name><surname>Carlson</surname><given-names>M</given-names></name></person-group><article-title>Glucose-regulated interaction of a regulatory subunit of protein phosphatase 1 with the Snf1 protein kinase in Saccharomyces cerevisiae</article-title><source>Proc Natl Acad Sci USA</source><year>1998</year><volume>95</volume><fpage>6245</fpage><lpage>6250</lpage></element-citation></ref><ref id="R66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maqani</surname><given-names>N</given-names></name><name><surname>Fine</surname><given-names>RD</given-names></name><name><surname>Shahid</surname><given-names>M</given-names></name><name><surname>Li</surname><given-names>M</given-names></name><name><surname>Enriquez-Hesles</surname><given-names>E</given-names></name><name><surname>Smith</surname><given-names>JS</given-names></name></person-group><article-title>Spontaneous mutations in CYC8 and MIG1 suppress the short chronological lifespan of budding yeast lacking SNF1/AMPK</article-title><source>Microb Cell</source><year>2018</year><volume>5</volume><fpage>233</fpage><lpage>248</lpage></element-citation></ref><ref id="R67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mayer</surname><given-names>FV</given-names></name><name><surname>Heath</surname><given-names>R</given-names></name><name><surname>Underwood</surname><given-names>E</given-names></name><name><surname>Sanders</surname><given-names>MJ</given-names></name><name><surname>Carmena</surname><given-names>D</given-names></name><name><surname>McCartney</surname><given-names>RR</given-names></name><name><surname>Leiper</surname><given-names>FC</given-names></name><name><surname>Xiao</surname><given-names>B</given-names></name><name><surname>Jing</surname><given-names>C</given-names></name><name><surname>Walker</surname><given-names>PA</given-names></name><etal/></person-group><article-title>ADP regulates SNF1, the Saccharomyces cerevisiae homolog of AMP-activated protein kinase</article-title><source>Cell Metab</source><year>2011</year><volume>14</volume><fpage>707</fpage><lpage>714</lpage></element-citation></ref><ref id="R68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McCartney</surname><given-names>RR</given-names></name><name><surname>Schmidt</surname><given-names>MC</given-names></name></person-group><article-title>Regulation of Snf1 kinase. Activation requires phosphorylation of threonine 210 by an upstream kinase as well as a distinct step mediated by the Snf4 subunit</article-title><source>J Biol Chem</source><year>2001</year><volume>276</volume><fpage>36460</fpage><lpage>36466</lpage></element-citation></ref><ref id="R69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Melick</surname><given-names>CH</given-names></name><name><surname>Jewell</surname><given-names>JL</given-names></name></person-group><article-title>Regulation of mTORC1 by Upstream Stimuli</article-title><source>Genes (Basel)</source><year>2020</year><volume>11</volume><fpage>989</fpage></element-citation></ref><ref id="R70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Messer</surname><given-names>K</given-names></name><name><surname>Natarajan</surname><given-names>L</given-names></name></person-group><article-title>Maximum likelihood, multiple imputation and regression calibration for measurement error adjustment</article-title><source>Stat Med</source><year>2008</year><volume>27</volume><fpage>6332</fpage><lpage>6350</lpage></element-citation></ref><ref id="R71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Michel</surname><given-names>AH</given-names></name><name><surname>Hatakeyama</surname><given-names>R</given-names></name><name><surname>Kimmig</surname><given-names>P</given-names></name><name><surname>Arter</surname><given-names>M</given-names></name><name><surname>Peter</surname><given-names>M</given-names></name><name><surname>Matos</surname><given-names>J</given-names></name><name><surname>De Virgilio</surname><given-names>C</given-names></name><name><surname>Kornmann</surname><given-names>B</given-names></name></person-group><article-title>Functional mapping of yeast genomes by saturated transposition</article-title><source>eLife</source><year>2017</year><volume>6</volume><elocation-id>e23570</elocation-id></element-citation></ref><ref id="R72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nada</surname><given-names>S</given-names></name><name><surname>Hondo</surname><given-names>A</given-names></name><name><surname>Kasai</surname><given-names>A</given-names></name><name><surname>Koike</surname><given-names>M</given-names></name><name><surname>Saito</surname><given-names>K</given-names></name><name><surname>Uchiyama</surname><given-names>Y</given-names></name><name><surname>Okada</surname><given-names>M</given-names></name></person-group><article-title>The novel lipid raft adaptor p18 controls endosome dynamics by anchoring the MEK-ERK pathway to late endosomes</article-title><source>EMBO J</source><year>2009</year><volume>28</volume><fpage>477</fpage><lpage>489</lpage></element-citation></ref><ref id="R73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nicastro</surname><given-names>R</given-names></name><name><surname>Sardu</surname><given-names>A</given-names></name><name><surname>Panchaud</surname><given-names>N</given-names></name><name><surname>De Virgilio</surname><given-names>C</given-names></name></person-group><article-title>The Architecture of the Rag GTPase Signaling Network</article-title><source>Biomolecules</source><year>2017</year><volume>7</volume><fpage>48</fpage></element-citation></ref><ref id="R74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nicastro</surname><given-names>R</given-names></name><name><surname>Tripodi</surname><given-names>F</given-names></name><name><surname>Gaggini</surname><given-names>M</given-names></name><name><surname>Castoldi</surname><given-names>A</given-names></name><name><surname>Reghellin</surname><given-names>V</given-names></name><name><surname>Nonnis</surname><given-names>S</given-names></name><name><surname>Tedeschi</surname><given-names>G</given-names></name><name><surname>Coccetti</surname><given-names>P</given-names></name></person-group><article-title>Snf1 phosphorylates adenylate cyclase and negatively regulates protein kinase A-dependent transcription in Saccharomyces cerevisiae</article-title><source>J Biol Chem</source><year>2015</year><volume>290</volume><fpage>24715</fpage><lpage>24726</lpage></element-citation></ref><ref id="R75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Novarina</surname><given-names>D</given-names></name><name><surname>Guerra</surname><given-names>P</given-names></name><name><surname>Milias-Argeitis</surname><given-names>A</given-names></name></person-group><article-title>Vacuolar localization via the N-terminal domain of Sch9 is required for TORC1-dependent phosphorylation and downstream signal transduction</article-title><source>J Mol Biol</source><year>2021</year><volume>433</volume><elocation-id>167326</elocation-id></element-citation></ref><ref id="R76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O’Donnell</surname><given-names>AF</given-names></name><name><surname>Schmidt</surname><given-names>MC</given-names></name></person-group><article-title>AMPK-mediated regulation of ⍺-arrestins and protein trafficking</article-title><source>Int J Mol Sci</source><year>2019</year><volume>20</volume><fpage>515</fpage></element-citation></ref><ref id="R77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olsen</surname><given-names>JV</given-names></name><name><surname>Blagoev</surname><given-names>B</given-names></name><name><surname>Gnad</surname><given-names>F</given-names></name><name><surname>Macek</surname><given-names>B</given-names></name><name><surname>Kumar</surname><given-names>C</given-names></name><name><surname>Mortensen</surname><given-names>P</given-names></name><name><surname>Mann</surname><given-names>M</given-names></name></person-group><article-title>Global, in vivo, and site-specific phosphorylation dynamics in signaling networks</article-title><source>Cell</source><year>2006</year><volume>127</volume><fpage>635</fpage><lpage>648</lpage></element-citation></ref><ref id="R78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ostling</surname><given-names>J</given-names></name><name><surname>Ronne</surname><given-names>H</given-names></name></person-group><article-title>Negative control of the Mig1p repressor by Snf1p-dependent phosphorylation in the absence of glucose</article-title><source>Eur J Biochem</source><year>1998</year><volume>252</volume><fpage>162</fpage><lpage>168</lpage></element-citation></ref><ref id="R79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Panchaud</surname><given-names>N</given-names></name><name><surname>Péli-Gulli</surname><given-names>MP</given-names></name><name><surname>De Virgilio</surname><given-names>C</given-names></name></person-group><article-title>Amino acid deprivation inhibits TORC1 through a GTPase-activating protein complex for the Rag family GTPase Gtr1</article-title><source>Sci Signal</source><year>2013a</year><volume>6</volume><elocation-id>ra42</elocation-id></element-citation></ref><ref id="R80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Panchaud</surname><given-names>N</given-names></name><name><surname>Péli-Gulli</surname><given-names>MP</given-names></name><name><surname>De Virgilio</surname><given-names>C</given-names></name></person-group><article-title>SEACing the GAP that nEGOCiates TORC1 activation: evolutionary conservation of Rag GTPase regulation</article-title><source>Cell Cycle</source><year>2013b</year><volume>12</volume><fpage>2948</fpage><lpage>2952</lpage></element-citation></ref><ref id="R81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Péli-Gulli</surname><given-names>MP</given-names></name><name><surname>Sardu</surname><given-names>A</given-names></name><name><surname>Panchaud</surname><given-names>N</given-names></name><name><surname>Raucci</surname><given-names>S</given-names></name><name><surname>De Virgilio</surname><given-names>C</given-names></name></person-group><article-title>Amino Acids Stimulate TORC1 through Lst4-Lst7, a GTPase-Activating Protein Complex for the Rag Family GTPase Gtr2</article-title><source>Cell Rep</source><year>2015</year><volume>13</volume><fpage>1</fpage><lpage>7</lpage></element-citation></ref><ref id="R82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peterson</surname><given-names>TR</given-names></name><name><surname>Laplante</surname><given-names>M</given-names></name><name><surname>Thoreen</surname><given-names>CC</given-names></name><name><surname>Sancak</surname><given-names>Y</given-names></name><name><surname>Kang</surname><given-names>SA</given-names></name><name><surname>Kuehl</surname><given-names>WM</given-names></name><name><surname>Gray</surname><given-names>NS</given-names></name><name><surname>Sabatini</surname><given-names>DM</given-names></name></person-group><article-title>DEPTOR is an mTOR inhibitor frequently overexpressed in multiple myeloma cells and required for their survival</article-title><source>Cell</source><year>2009</year><volume>137</volume><fpage>873</fpage><lpage>886</lpage></element-citation></ref><ref id="R83"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petit</surname><given-names>CS</given-names></name><name><surname>Roczniak-Ferguson</surname><given-names>A</given-names></name><name><surname>Ferguson</surname><given-names>SM</given-names></name></person-group><article-title>Recruitment of folliculin to lysosomes supports the amino acid-dependent activation of Rag GTPases</article-title><source>J Cell Biol</source><year>2013</year><volume>202</volume><fpage>1107</fpage><lpage>1122</lpage></element-citation></ref><ref id="R84"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petrenko</surname><given-names>N</given-names></name><name><surname>Chereji</surname><given-names>RV</given-names></name><name><surname>McClean</surname><given-names>MN</given-names></name><name><surname>Morozov</surname><given-names>AV</given-names></name><name><surname>Broach</surname><given-names>JR</given-names></name></person-group><article-title>Noise and interlocking signaling pathways promote distinct transcription factor dynamics in response to different stresses</article-title><source>Mol Biol Cell</source><year>2013</year><volume>24</volume><fpage>2045</fpage><lpage>2057</lpage></element-citation></ref><ref id="R85"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Post</surname><given-names>H</given-names></name><name><surname>Penning</surname><given-names>R</given-names></name><name><surname>Fitzpatrick</surname><given-names>MA</given-names></name><name><surname>Garrigues</surname><given-names>LB</given-names></name><name><surname>Wu</surname><given-names>W</given-names></name><name><surname>MacGillavry</surname><given-names>HD</given-names></name><name><surname>Hoogenraad</surname><given-names>CC</given-names></name><name><surname>Heck</surname><given-names>AJ</given-names></name><name><surname>Altelaar</surname><given-names>AF</given-names></name></person-group><article-title>Robust, Sensitive, and Automated Phosphopeptide Enrichment Optimized for Low Sample Amounts Applied to Primary Hippocampal Neurons</article-title><source>J Proteome Res</source><year>2017</year><volume>16</volume><fpage>728</fpage><lpage>737</lpage></element-citation></ref><ref id="R86"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Powis</surname><given-names>K</given-names></name><name><surname>De Virgilio</surname><given-names>C</given-names></name></person-group><article-title>Conserved regulators of Rag GTPases orchestrate amino acid-dependent TORC1 signaling</article-title><source>Cell Discov</source><year>2016</year><volume>2</volume><elocation-id>15049</elocation-id></element-citation></ref><ref id="R87"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Powis</surname><given-names>K</given-names></name><name><surname>Zhang</surname><given-names>T</given-names></name><name><surname>Panchaud</surname><given-names>N</given-names></name><name><surname>Wang</surname><given-names>R</given-names></name><name><surname>De Virgilio</surname><given-names>C</given-names></name><name><surname>Ding</surname><given-names>J</given-names></name></person-group><article-title>Crystal structure of the Ego1-Ego2-Ego3 complex and its role in promoting Rag GTPase-dependent TORC1 signaling</article-title><source>Cell Res</source><year>2015</year><volume>25</volume><fpage>1043</fpage><lpage>1059</lpage></element-citation></ref><ref id="R88"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ptacek</surname><given-names>J</given-names></name><name><surname>Devgan</surname><given-names>G</given-names></name><name><surname>Michaud</surname><given-names>G</given-names></name><name><surname>Zhu</surname><given-names>H</given-names></name><name><surname>Zhu</surname><given-names>X</given-names></name><name><surname>Fasolo</surname><given-names>J</given-names></name><name><surname>Guo</surname><given-names>H</given-names></name><name><surname>Jona</surname><given-names>G</given-names></name><name><surname>Breitkreutz</surname><given-names>A</given-names></name><name><surname>Sopko</surname><given-names>R</given-names></name><etal/></person-group><article-title>Global analysis of protein phosphorylation in yeast</article-title><source>Nature</source><year>2005</year><volume>438</volume><fpage>679</fpage><lpage>684</lpage></element-citation></ref><ref id="R89"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reinke</surname><given-names>A</given-names></name><name><surname>Anderson</surname><given-names>S</given-names></name><name><surname>McCaffery</surname><given-names>JM</given-names></name><name><surname>Yates</surname><given-names>J</given-names><suffix>3rd</suffix></name><name><surname>Aronova</surname><given-names>S</given-names></name><name><surname>Chu</surname><given-names>S</given-names></name><name><surname>Fairclough</surname><given-names>S</given-names></name><name><surname>Iverson</surname><given-names>C</given-names></name><name><surname>Wedaman</surname><given-names>KP</given-names></name><name><surname>Powers</surname><given-names>T</given-names></name></person-group><article-title>TOR complex 1 includes a novel component, Tco89p (YPL180w), and cooperates with Ssd1p to maintain cellular integrity in Saccharomyces cerevisiae</article-title><source>J Biol Chem</source><year>2004</year><volume>279</volume><fpage>14752</fpage><lpage>14762</lpage></element-citation></ref><ref id="R90"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rogala</surname><given-names>KB</given-names></name><name><surname>Gu</surname><given-names>X</given-names></name><name><surname>Kedir</surname><given-names>JF</given-names></name><name><surname>Abu-Remaileh</surname><given-names>M</given-names></name><name><surname>Bianchi</surname><given-names>LF</given-names></name><name><surname>Bottino</surname><given-names>AMS</given-names></name><name><surname>Dueholm</surname><given-names>R</given-names></name><name><surname>Niehaus</surname><given-names>A</given-names></name><name><surname>Overwijn</surname><given-names>D</given-names></name><name><surname>Fils</surname><given-names>AP</given-names></name><etal/></person-group><article-title>Structural basis for the docking of mTORC1 on the lysosomal surface</article-title><source>Science</source><year>2019</year><volume>366</volume><fpage>468</fpage><lpage>475</lpage></element-citation></ref><ref id="R91"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ruiz</surname><given-names>A</given-names></name><name><surname>Xu</surname><given-names>X</given-names></name><name><surname>Carlson</surname><given-names>M</given-names></name></person-group><article-title>Ptc1 protein phosphatase 2C contributes to glucose regulation of SNF1/AMP-activated protein kinase (AMPK) in Saccharomyces cerevisiae</article-title><source>J Biol Chem</source><year>2013</year><volume>288</volume><fpage>31052</fpage><lpage>31058</lpage></element-citation></ref><ref id="R92"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saliba</surname><given-names>E</given-names></name><name><surname>Evangelinos</surname><given-names>M</given-names></name><name><surname>Gournas</surname><given-names>C</given-names></name><name><surname>Corrillon</surname><given-names>F</given-names></name><name><surname>Georis</surname><given-names>I</given-names></name><name><surname>Andre</surname><given-names>B</given-names></name></person-group><article-title>The yeast H<sup>+</sup>-ATPase Pma1 promotes Rag/Gtr-dependent TORC1 activation in response to H<sup>+</sup>-coupled nutrient uptake</article-title><source>Elife</source><year>2018</year><volume>7</volume><elocation-id>e31981</elocation-id></element-citation></ref><ref id="R93"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sancak</surname><given-names>Y</given-names></name><name><surname>Bar-Peled</surname><given-names>L</given-names></name><name><surname>Zoncu</surname><given-names>R</given-names></name><name><surname>Markhard</surname><given-names>AL</given-names></name><name><surname>Nada</surname><given-names>S</given-names></name><name><surname>Sabatini</surname><given-names>DM</given-names></name></person-group><article-title>Ragulator-Rag complex targets mTORC1 to the lysosomal surface and is necessary for its activation by amino acids</article-title><source>Cell</source><year>2010</year><volume>141</volume><fpage>290</fpage><lpage>303</lpage></element-citation></ref><ref id="R94"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sancak</surname><given-names>Y</given-names></name><name><surname>Thoreen</surname><given-names>CC</given-names></name><name><surname>Peterson</surname><given-names>TR</given-names></name><name><surname>Lindquist</surname><given-names>RA</given-names></name><name><surname>Kang</surname><given-names>SA</given-names></name><name><surname>Spooner</surname><given-names>E</given-names></name><name><surname>Carr</surname><given-names>SA</given-names></name><name><surname>Sabatini</surname><given-names>DM</given-names></name></person-group><article-title>PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase</article-title><source>Mol Cell</source><year>2007</year><volume>25</volume><fpage>903</fpage><lpage>915</lpage></element-citation></ref><ref id="R95"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanz</surname><given-names>P</given-names></name><name><surname>Alms</surname><given-names>GR</given-names></name><name><surname>Haystead</surname><given-names>TA</given-names></name><name><surname>Carlson</surname><given-names>M</given-names></name></person-group><article-title>Regulatory interactions between the Reg1-Glc7 protein phosphatase and the Snf1 protein kinase</article-title><source>Mol Cell Biol</source><year>2000</year><volume>20</volume><fpage>1321</fpage><lpage>1328</lpage></element-citation></ref><ref id="R96"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schaffer</surname><given-names>BE</given-names></name><name><surname>Levin</surname><given-names>RS</given-names></name><name><surname>Hertz</surname><given-names>NT</given-names></name><name><surname>Maures</surname><given-names>TJ</given-names></name><name><surname>Schoof</surname><given-names>ML</given-names></name><name><surname>Hollstein</surname><given-names>PE</given-names></name><name><surname>Benayoun</surname><given-names>BA</given-names></name><name><surname>Banko</surname><given-names>MR</given-names></name><name><surname>Shaw</surname><given-names>RJ</given-names></name><name><surname>Shokat</surname><given-names>KM</given-names></name><name><surname>Brunet</surname><given-names>A</given-names></name></person-group><article-title>Identification of AMPK Phosphorylation Sites Reveals a Network of Proteins Involved in Cell Invasion and Facilitates Large- Scale Substrate Prediction</article-title><source>Cell Metab</source><year>2015</year><volume>22</volume><fpage>907</fpage><lpage>921</lpage></element-citation></ref><ref id="R97"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scott</surname><given-names>JW</given-names></name><name><surname>Norman</surname><given-names>DG</given-names></name><name><surname>Hawley</surname><given-names>SA</given-names></name><name><surname>Kontogiannis</surname><given-names>L</given-names></name><name><surname>Hardie</surname><given-names>DG</given-names></name></person-group><article-title>Protein kinase substrate recognition studied using the recombinant catalytic domain of AMP-activated protein kinase and a model substrate</article-title><source>J Mol Biol</source><year>2002</year><volume>317</volume><fpage>309</fpage><lpage>323</lpage></element-citation></ref><ref id="R98"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shaw</surname><given-names>RJ</given-names></name><name><surname>Bardeesy</surname><given-names>N</given-names></name><name><surname>Manning</surname><given-names>BD</given-names></name><name><surname>Lopez</surname><given-names>L</given-names></name><name><surname>Kosmatka</surname><given-names>M</given-names></name><name><surname>DePinho</surname><given-names>RA</given-names></name><name><surname>Cantley</surname><given-names>LC</given-names></name></person-group><article-title>The LKB1 tumor suppressor negatively regulates mTOR signaling</article-title><source>Cancer Cell</source><year>2004</year><volume>6</volume><fpage>91</fpage><lpage>99</lpage></element-citation></ref><ref id="R99"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shen</surname><given-names>K</given-names></name><name><surname>Choe</surname><given-names>A</given-names></name><name><surname>Sabatini</surname><given-names>DM</given-names></name></person-group><article-title>Intersubunit crosstalk in the Rag GTPase heterodimer enables mTORC1 to respond rapidly to amino acid availability</article-title><source>Mol Cell</source><year>2017</year><volume>68</volume><fpage>552</fpage><lpage>565</lpage><elocation-id>e558</elocation-id></element-citation></ref><ref id="R100"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shinoda</surname><given-names>J</given-names></name><name><surname>Kikuchi</surname><given-names>Y</given-names></name></person-group><article-title>Rod1, an arrestin-related protein, is phosphorylated by Snf1-kinase in Saccharomyces cerevisiae</article-title><source>Biochem Biophys Res Commun</source><year>2007</year><volume>364</volume><fpage>258</fpage><lpage>263</lpage></element-citation></ref><ref id="R101"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shirra</surname><given-names>MK</given-names></name><name><surname>McCartney</surname><given-names>RR</given-names></name><name><surname>Zhang</surname><given-names>C</given-names></name><name><surname>Shokat</surname><given-names>KM</given-names></name><name><surname>Schmidt</surname><given-names>MC</given-names></name><name><surname>Arndt</surname><given-names>KM</given-names></name></person-group><article-title>A chemical genomics study identifies Snf1 as a repressor of GCN4 translation</article-title><source>J Biol Chem</source><year>2008</year><volume>283</volume><fpage>35889</fpage><lpage>35898</lpage></element-citation></ref><ref id="R102"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>FC</given-names></name><name><surname>Davies</surname><given-names>SP</given-names></name><name><surname>Wilson</surname><given-names>WA</given-names></name><name><surname>Carling</surname><given-names>D</given-names></name><name><surname>Hardie</surname><given-names>DG</given-names></name></person-group><article-title>The SNF1 kinase complex from Saccharomyces cerevisiae phosphorylates the transcriptional repressor protein Mig1p in vitro at four sites within or near regulatory domain 1</article-title><source>FEBS Lett</source><year>1999</year><volume>453</volume><fpage>219</fpage><lpage>223</lpage></element-citation></ref><ref id="R103"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stracka</surname><given-names>D</given-names></name><name><surname>Jozefczuk</surname><given-names>S</given-names></name><name><surname>Rudroff</surname><given-names>F</given-names></name><name><surname>Sauer</surname><given-names>U</given-names></name><name><surname>Hall</surname><given-names>MN</given-names></name></person-group><article-title>Nitrogen source activates TOR (target of rapamycin) complex 1 via glutamine and independently of Gtr/Rag proteins</article-title><source>J Biol Chem</source><year>2014</year><volume>289</volume><fpage>25010</fpage><lpage>25020</lpage></element-citation></ref><ref id="R104"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sullivan</surname><given-names>A</given-names></name><name><surname>Wallace</surname><given-names>RL</given-names></name><name><surname>Wellington</surname><given-names>R</given-names></name><name><surname>Luo</surname><given-names>X</given-names></name><name><surname>Capaldi</surname><given-names>AP</given-names></name></person-group><article-title>Multilayered regulation of TORC1-body formation in budding yeast</article-title><source>Mol Biol Cell</source><year>2019</year><volume>30</volume><fpage>400</fpage><lpage>410</lpage></element-citation></ref><ref id="R105"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Szklarczyk</surname><given-names>D</given-names></name><name><surname>Gable</surname><given-names>AL</given-names></name><name><surname>Nastou</surname><given-names>KC</given-names></name><name><surname>Lyon</surname><given-names>D</given-names></name><name><surname>Kirsch</surname><given-names>R</given-names></name><name><surname>Pyysalo</surname><given-names>S</given-names></name><name><surname>Doncheva</surname><given-names>NT</given-names></name><name><surname>Legeay</surname><given-names>M</given-names></name><name><surname>Fang</surname><given-names>T</given-names></name><name><surname>Bork</surname><given-names>P</given-names></name><etal/></person-group><article-title>The STRING database in 2021: customizable protein-protein networks, and functional characterization of user-uploaded gene/measurement sets</article-title><source>Nucleic Acids Res</source><year>2021</year><volume>49</volume><fpage>D605</fpage><lpage>D612</lpage></element-citation></ref><ref id="R106"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tanigawa</surname><given-names>M</given-names></name><name><surname>Maeda</surname><given-names>T</given-names></name></person-group><article-title>An in vitro TORC1 kinase assay that recapitulates the Gtr-independent glutamine-responsive TORC1 activation mechanism on yeast vacuoles</article-title><source>Mol Cell Biol</source><year>2017</year><volume>37</volume></element-citation></ref><ref id="R107"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tanigawa</surname><given-names>M</given-names></name><name><surname>Yamamoto</surname><given-names>K</given-names></name><name><surname>Nagatoishi</surname><given-names>S</given-names></name><name><surname>Nagata</surname><given-names>K</given-names></name><name><surname>Noshiro</surname><given-names>D</given-names></name><name><surname>Noda</surname><given-names>NN</given-names></name><name><surname>Tsumoto</surname><given-names>K</given-names></name><name><surname>Maeda</surname><given-names>T</given-names></name></person-group><article-title>A glutamine sensor that directly activates TORC1</article-title><source>Commun Biol</source><year>2021</year><volume>4</volume><fpage>1093</fpage></element-citation></ref><ref id="R108"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tee</surname><given-names>AR</given-names></name><name><surname>Manning</surname><given-names>BD</given-names></name><name><surname>Roux</surname><given-names>PP</given-names></name><name><surname>Cantley</surname><given-names>LC</given-names></name><name><surname>Blenis</surname><given-names>J</given-names></name></person-group><article-title>Tuberous sclerosis complex gene products, Tuberin and Hamartin, control mTOR signaling by acting as a GTPase-activating protein complex toward Rheb</article-title><source>Curr Biol</source><year>2003</year><volume>13</volume><fpage>1259</fpage><lpage>1268</lpage></element-citation></ref><ref id="R109"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Treitel</surname><given-names>MA</given-names></name><name><surname>Kuchin</surname><given-names>S</given-names></name><name><surname>Carlson</surname><given-names>M</given-names></name></person-group><article-title>Snf1 protein kinase regulates phosphorylation of the Mig1 repressor in Saccharomyces cerevisiae</article-title><source>Mol Cell Biol</source><year>1998</year><volume>18</volume><fpage>6273</fpage><lpage>6280</lpage></element-citation></ref><ref id="R110"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Troutman</surname><given-names>KK</given-names></name><name><surname>Varlakhanova</surname><given-names>NV</given-names></name><name><surname>Tornabene</surname><given-names>BA</given-names></name><name><surname>Ramachandran</surname><given-names>R</given-names></name><name><surname>Ford</surname><given-names>MGJ</given-names></name></person-group><article-title>Conserved Pib2 regions have distinct roles in TORC1 regulation at the vacuole</article-title><source>J Cell Sci</source><year>2022</year><volume>135</volume><elocation-id>jcs259994</elocation-id></element-citation></ref><ref id="R111"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsun</surname><given-names>ZY</given-names></name><name><surname>Bar-Peled</surname><given-names>L</given-names></name><name><surname>Chantranupong</surname><given-names>L</given-names></name><name><surname>Zoncu</surname><given-names>R</given-names></name><name><surname>Wang</surname><given-names>T</given-names></name><name><surname>Kim</surname><given-names>C</given-names></name><name><surname>Spooner</surname><given-names>E</given-names></name><name><surname>Sabatini</surname><given-names>DM</given-names></name></person-group><article-title>The folliculin tumor suppressor is a GAP for the RagC/D GTPases that signal amino acid levels to mTORC1</article-title><source>Mol Cell</source><year>2013</year><volume>52</volume><fpage>495</fpage><lpage>505</lpage></element-citation></ref><ref id="R112"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tyanova</surname><given-names>S</given-names></name><name><surname>Temu</surname><given-names>T</given-names></name><name><surname>Cox</surname><given-names>J</given-names></name></person-group><article-title>The MaxQuant computational platform for mass spectrometry-based shotgun proteomics</article-title><source>Nat Protoc</source><year>2016</year><volume>11</volume><fpage>2301</fpage><lpage>2319</lpage></element-citation></ref><ref id="R113"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ukai</surname><given-names>H</given-names></name><name><surname>Araki</surname><given-names>Y</given-names></name><name><surname>Kira</surname><given-names>S</given-names></name><name><surname>Oikawa</surname><given-names>Y</given-names></name><name><surname>May</surname><given-names>AI</given-names></name><name><surname>Noda</surname><given-names>T</given-names></name></person-group><article-title>Gtr/Ego-independent TORC1 activation is achieved through a glutamine-sensitive interaction with Pib2 on the vacuolar membrane</article-title><source>PLoS Genet</source><year>2018</year><volume>14</volume><elocation-id>e1007334</elocation-id></element-citation></ref><ref id="R114"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Urban</surname><given-names>J</given-names></name><name><surname>Soulard</surname><given-names>A</given-names></name><name><surname>Huber</surname><given-names>A</given-names></name><name><surname>Lippman</surname><given-names>S</given-names></name><name><surname>Mukhopadhyay</surname><given-names>D</given-names></name><name><surname>Deloche</surname><given-names>O</given-names></name><name><surname>Wanke</surname><given-names>V</given-names></name><name><surname>Anrather</surname><given-names>D</given-names></name><name><surname>Ammerer</surname><given-names>G</given-names></name><name><surname>Riezman</surname><given-names>H</given-names></name><etal/></person-group><article-title>Sch9 is a major target of TORC1 in Saccharomyces cerevisiae</article-title><source>Mol Cell</source><year>2007</year><volume>26</volume><fpage>663</fpage><lpage>674</lpage></element-citation></ref><ref id="R115"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Varlakhanova</surname><given-names>NV</given-names></name><name><surname>Mihalevic</surname><given-names>MJ</given-names></name><name><surname>Bernstein</surname><given-names>KA</given-names></name><name><surname>Ford</surname><given-names>MGJ</given-names></name></person-group><article-title>Pib2 and the EGO complex are both required for activation of TORC1</article-title><source>J Cell Sci</source><year>2017</year><volume>130</volume><fpage>3878</fpage><lpage>3890</lpage></element-citation></ref><ref id="R116"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Varlakhanova</surname><given-names>NV</given-names></name><name><surname>Tornabene</surname><given-names>BA</given-names></name><name><surname>Ford</surname><given-names>MGJ</given-names></name></person-group><article-title>Feedback regulation of TORC1 by its downstream effectors Npr1 and Par32</article-title><source>Mol Biol Cell</source><year>2018</year><volume>29</volume><fpage>2751</fpage><lpage>2765</lpage></element-citation></ref><ref id="R117"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wei</surname><given-names>M</given-names></name><name><surname>Fabrizio</surname><given-names>P</given-names></name><name><surname>Hu</surname><given-names>J</given-names></name><name><surname>Ge</surname><given-names>H</given-names></name><name><surname>Cheng</surname><given-names>C</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Longo</surname><given-names>VD</given-names></name></person-group><article-title>Life span extension by calorie restriction depends on Rim15 and transcription factors downstream of Ras/PKA, Tor, and Sch9</article-title><source>PLoS Genet</source><year>2008</year><volume>4</volume><fpage>e13</fpage></element-citation></ref><ref id="R118"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wierman</surname><given-names>MB</given-names></name><name><surname>Maqani</surname><given-names>N</given-names></name><name><surname>Strickler</surname><given-names>E</given-names></name><name><surname>Li</surname><given-names>M</given-names></name><name><surname>Smith</surname><given-names>JS</given-names></name></person-group><article-title>Caloric restriction extends yeast chronological life span by optimizing the Snf1 (AMPK) signaling pathway</article-title><source>Mol Cell Biol</source><year>2017</year><volume>37</volume></element-citation></ref><ref id="R119"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilson</surname><given-names>WA</given-names></name><name><surname>Hawley</surname><given-names>SA</given-names></name><name><surname>Hardie</surname><given-names>DG</given-names></name></person-group><article-title>Glucose repression/derepression in budding yeast: SNF1 protein kinase is activated by phosphorylation under derepressing conditions, and this correlates with a high AMP:ATP ratio</article-title><source>Curr Biol</source><year>1996</year><volume>6</volume><fpage>1426</fpage><lpage>1434</lpage></element-citation></ref><ref id="R120"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wolfson</surname><given-names>RL</given-names></name><name><surname>Sabatini</surname><given-names>DM</given-names></name></person-group><article-title>The dawn of the age of amino acid sensors for the mTORC1 pathway</article-title><source>Cell Metab</source><year>2017</year><volume>26</volume><fpage>301</fpage><lpage>309</lpage></element-citation></ref><ref id="R121"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wullschleger</surname><given-names>S</given-names></name><name><surname>Loewith</surname><given-names>R</given-names></name><name><surname>Hall</surname><given-names>MN</given-names></name></person-group><article-title>TOR signaling in growth and metabolism</article-title><source>Cell</source><year>2006</year><volume>124</volume><fpage>471</fpage><lpage>484</lpage></element-citation></ref><ref id="R122"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>H</given-names></name><name><surname>Jiang</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>B</given-names></name><name><surname>Yang</surname><given-names>HJ</given-names></name><name><surname>Miller</surname><given-names>M</given-names></name><name><surname>Yang</surname><given-names>A</given-names></name><name><surname>Dhar</surname><given-names>A</given-names></name><name><surname>Pavletich</surname><given-names>NP</given-names></name></person-group><article-title>Mechanisms of mTORC1 activation by RHEB and inhibition by PRAS40</article-title><source>Nature</source><year>2017</year><volume>552</volume><fpage>368</fpage><lpage>373</lpage></element-citation></ref><ref id="R123"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zaman</surname><given-names>S</given-names></name><name><surname>Lippman</surname><given-names>SI</given-names></name><name><surname>Schneper</surname><given-names>L</given-names></name><name><surname>Slonim</surname><given-names>N</given-names></name><name><surname>Broach</surname><given-names>JR</given-names></name></person-group><article-title>Glucose regulates transcription in yeast through a network of signaling pathways</article-title><source>Mol Syst Biol</source><year>2009</year><volume>5</volume><fpage>245</fpage></element-citation></ref><ref id="R124"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zarei</surname><given-names>M</given-names></name><name><surname>Sprenger</surname><given-names>A</given-names></name><name><surname>Rackiewicz</surname><given-names>M</given-names></name><name><surname>Dengjel</surname><given-names>J</given-names></name></person-group><article-title>Fast and easy phosphopeptide fractionation by combinatorial ERLIC-SCX solid-phase extraction for in-depth phosphoproteome analysis</article-title><source>Nat Protoc</source><year>2016</year><volume>11</volume><fpage>37</fpage><lpage>45</lpage></element-citation></ref><ref id="R125"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zbieralski</surname><given-names>K</given-names></name><name><surname>Wawrzycka</surname><given-names>D</given-names></name></person-group><article-title>⍺-Arrestins and their functions: from yeast to human health</article-title><source>Int J Mol Sci</source><year>2022</year><volume>23</volume><fpage>4988</fpage></element-citation></ref><ref id="R126"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname><given-names>L</given-names></name><name><surname>Zhang</surname><given-names>W</given-names></name><name><surname>Zhou</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>F</given-names></name><name><surname>Wei</surname><given-names>H</given-names></name><name><surname>Peng</surname><given-names>J</given-names></name></person-group><article-title>Recent advances in understanding amino acid sensing mechanisms that regulate mTORC1</article-title><source>Int J Mol Sci</source><year>2016</year><volume>17</volume><fpage>1636</fpage></element-citation></ref></ref-list></back><floats-group><fig id="F1" position="float"><label>Figure 1</label><caption><title>Snf1 is required for proper downregulation of TORC1 in glucose-starved cells.</title><p>(<bold>A, B</bold>) Wild-type (WT), <italic>snf1Δ</italic>, and <italic>snf1</italic><sup><italic>as</italic></sup> (analog-sensitive) cells were grown exponentially (Exp) and starved for glucose for 10 min (-C) in the absence (-; DMSO vehicle control) or presence (+) of 2NM-PP1. Phosphorylation of the <italic>bona fide</italic> TORC1 target residue Thr<sup>737</sup> in Sch9 and of Thr<sup>210</sup> in Snf1 was detected by immunoblot analyses of whole cell extracts using phospho-specific antibodies against the respective phospho-residues. Anti-Sch9 and anti-His<sub>6</sub> antibodies served to detect the levels of Sch9 and Snf1, respectively (A). Notably, binding of 2NM-PP1 to the catalytic cleft of Snf1<sup>as</sup> inhibits its kinase activity and, at the same time, prevents the dephosphorylation of phosphorylated Thr<sup>210</sup> (pThr<sup>210</sup>) in Snf1 (<xref ref-type="bibr" rid="R17">Chandrashekarappa et al., 2013</xref>). The mean TORC1 activities (<italic>i</italic>.<italic>e</italic>. Sch9-pThr<sup>737</sup>/Sch9) were quantified, normalized relative to exponentially growing WT cells (set to 1.0), and shown in the bar diagram in (B) (n=4; + SEM; unpaired Student’s t-test, *p ≤ 0.05). (<bold>C, D</bold>) Analog-sensitive <italic>snf1</italic><sup><italic>as</italic></sup> cells were treated as in (A), but harvested at the times indicated following glucose starvation (-C). The respective relative TORC1 activities were assessed as in (B) and are shown in (D) (n=4; + SEM; unpaired Student’s t-test, *p ≤ 0.05). (<bold>E</bold>) WT and <italic>reg1∆</italic> cells were grown exponentially and assayed for their mean relative TORC1 activities (Sch9-pThr<sup>737</sup>/Sch9) and Snf1-Thr<sup>210</sup> phosphorylation levels (Snf1-pThr<sup>210</sup>/Snf1), each normalized to WT cells (set to 1.0; n=4; ± SEM). In unpaired Student’s tests, both values in <italic>reg1∆</italic> cells were significantly different from the ones in WT cells (*p ≤ 0.05). (<bold>F</bold>) Exponentially growing cells (of the indicated genotype) were 10-fold serially diluted, spotted on synthetic complete medium containing, or not (control), 3 nM rapamycin, and grown for 3 days at 30°C (n=3).</p></caption><graphic xlink:href="EMS155982-f001"/></fig><fig id="F2" position="float"><label>Figure 2</label><caption><title>Snf1 prevents transient TORC1 restimulation by glutamine in glucose- and glutamine-starved cells.</title><p>(<bold>A-F</bold>) Exponentially growing <italic>snf1</italic><sup><italic>as</italic></sup> cells were starved for 20 min for nitrogen and glucose (-N, -C) and then restimulated for the times indicated, in the absence (DMSO) or presence of 2NM-PP1, with 2% glucose (Glc) (A, B), 2% glucose and 3.3 mM glutamine (Gln) (C, D), or 3.3 mM glutamine (E, F). Immunoblot analyses were performed as in <xref ref-type="fig" rid="F1">Fig. 1A</xref> and the relative TORC1 activities in (A), (C), and (E), were quantified as in <xref ref-type="fig" rid="F1">Fig. 1B</xref> and are shown in (B), (D), and (F), respectively (n=3; + SEM; unpaired Student’s t-test, *p ≤ 0.05).</p></caption><graphic xlink:href="EMS155982-f002"/></fig><fig id="F3" position="float"><label>Figure 3</label><caption><title>Quantitative phosphoproteomic analyses for the identification of potential Snf1 target sites.</title><p>(<bold>A</bold>)Quantitative MS-based proteomics workflow (SILAC n=5, OBIKA n=5). (<bold>B</bold>) Histogram of the number of identified phosphosites in the SILAC analysis after each filtering step and the relative amount of phosphosites attributed to classes I and II among the significant ones. (<bold>C</bold>) Proportional Venn diagram highlighting the commonly identified phosphosites in the current and two recent Snf1 phosphoproteomic studies. (<bold>D</bold>) Heatmap of phosphosite kinetics. Normalized SILAC ratios (treated <italic>versus</italic> non-treated) of class I and class II sites (highlighted in B) were log2 transformed and z normalized prior unsupervised hierarchical clustering of the rows tree using Euclidean distance as matrix. Five major clusters <italic>a-e</italic>, each highlighted by a different color, are observed. <bold>(E</bold>) Motif analyses of Snf1 phosphosites identified by <italic>in vivo</italic> SILAC and OBIKA experiments as outlined in (A). <bold>(F)</bold> Protein-protein interaction network comprising 57 interconnected proteins out of the 98 where at least one Snf1-dependent phosphosite was shortlisted by the intersection of the SILAC and OBIKA analyses. The network was generated with Cytoscape using the STRING plugin, setting the confidence (score) cut-off at 0.25. Edge thickness represents the score value of each interaction. (<bold>G</bold>) Schematic model representing components of the Snf1/AMPK and TORC1 signaling pathways that contain Snf1-regulated phosphosites. Phosphosites attributed to class II are highlighted with a bold-pink outline. The 3 Snf1 β-subunits are represented with a dashed outline on the left. Solid and dashed arrows refer to direct and indirect activating interactions, respectively. Dashed lines with bars refer to potential (question marks) inhibitory interactions that are experimentally addressed in the indicated figures in this study.</p></caption><graphic xlink:href="EMS155982-f003"/></fig><fig id="F4" position="float"><label>Figure 4</label><caption><p>Snf1 weakens the Pib2-Kog1 association by phosphorylating Pib2-Ser<sup>268,309</sup> (<bold>A</bold>) Schematic representation of the structure of Pib2 with the N-terminal TORC1-inhibitory (NID), Kog1-binding (Kog1-BD), phosphatidylinositol-3-phosphate (PI3P) -binding Fab1-YOTB-Vac1-EEA1 (FYVE), and C-terminal TORC1-activatory (CAD) domains (<xref ref-type="bibr" rid="R39">Hatakeyama, 2021</xref>). The residues Ser<sup>268</sup> and Ser<sup>309</sup> in Pib2 were both identified as potential Snf1 targets (P) <italic>in vivo</italic> (SILAC), while only Ser<sup>309</sup> was recovered in our highly multiplexed on-beads <italic>in vitro</italic> kinase assays (OBIKA) with Snf1. (<bold>B, C</bold>) Snf1 controls the phosphorylation of Ser<sup>268</sup> and Ser<sup>309</sup> in Pib2 <italic>in vivo</italic>. Phosphorylation levels of Pib2-Ser<sup>268</sup> (B) and Pib2-Ser<sup>309</sup> (C) in untreated (DMSO) and 2NM-PP1-treated <italic>snf1</italic><sup><italic>as</italic></sup> cells that were grown exponentially (Exp) and limited for glucose (0.05%) for the times indicated. Mean values were extracted from the SILAC experiment (<xref ref-type="supplementary-material" rid="SD2">Supplementary table 4</xref> and <xref ref-type="fig" rid="F3">Fig. 3</xref>) and normalized to the ones in exponentially growing cells (set to 1.0) (n=3; + SD; unpaired Student’s t-test, *FDR ≤ 0.05). (<bold>D</bold>) Snf1 phosphorylates Ser<sup>268</sup> and Ser<sup>309</sup> in Pib2 <italic>in vitro</italic>. Snf1 (WT) and kinase-inactive Snf1<sup>T210A</sup> (TA) were purified from yeast and used in protein kinase assays with [γ-<sup>32</sup>P]-ATP and a bacterially-expressed fragment of Pib2 (Pib2<sup>221-635</sup>) lacking the N-terminal 220 amino acids that, according to our <italic>in vivo</italic> proteomics analyses, did not contain a potential Snf1 target residue. In parallel protein kinase assays, we also used the respective Pib2<sup>S268A</sup>, Pib2<sup>S309A</sup>, and Pib2<sup>S268A/S309A</sup> (Pib2<sup>SASA</sup>) mutant fragments as substrates. Substrate phosphorylation was detected by autoradiography (<sup>32</sup>P, upper blot) and Sypro Ruby (SyR, lower blot) staining is shown as loading control. The mean phosphorylation of the Pib2<sup>S268A</sup>, Pib2<sup>S309A</sup>, and Pib2<sup>S268A/S309A</sup> (Pib2<sup>SASA</sup>) fragments by wild-type Snf1 (<italic>i</italic>.<italic>e</italic>. <sup>32</sup>P signal/Sypro Ruby [SyR] substrate input level; nd, not detected) was assessed relative to the one of the Pib2<sup>WT</sup> fragment (set to 1.0; n=3; ± SEM; unpaired Student’s t-test, *p ≤ 0.05). (<bold>E</bold>) The Snf1 complex binds Pib2. The binding affinity between bacterially purified, titrated Pib2<sup>221-635</sup> and yeast purified Snf1 complex (containing the C-terminally GFP-tagged Snf4 γ-subunit) was assessed by microscale thermophoresis. The dissociation constant (K<sub>D</sub>; 95% profile likelihood = 136 – 1098 nM, n=3; ± SEM) was calculated using a nonlinear asymmetric sigmoidal regression. (<bold>F, G</bold>) Expression of the phosphomimetic Pib2<sup>S268E,S309E</sup> allele, like loss of Pib2, rescues the TORC1 inactivation defect in glucose-starved, Snf1-compromised cells. Exponentially growing <italic>snf1</italic><sup><italic>as</italic></sup>, <italic>snf1</italic><sup><italic>as</italic></sup> <italic>pib2∆, snf1</italic><sup><italic>as</italic></sup> <italic>pib2</italic><sup><italic>S268A,S309A</italic></sup> (<italic>pib2</italic><sup><italic>SASA</italic></sup>), and <italic>snf1</italic><sup><italic>as</italic></sup> <italic>pib2</italic><sup><italic>S268E,S309E</italic></sup> (<italic>pib2</italic><sup><italic>SESE</italic></sup>) cells were grown exponentially (Exp) and then starved for 10 min for glucose (-C) in the absence (-; DMSO) or the presence (+) of 2NM-PP1. Immunoblot analyses of Sch9-pThr<sup>737</sup> and Sch9 (left blots) and of Snf1<sup>as</sup>-pThr<sup>210</sup> and Snf1<sup>as</sup> (right blots) were carried out as in <xref ref-type="fig" rid="F1">Fig. 1A (F)</xref>. The mean relative TORC1 activities in the four strains were quantified as in <xref ref-type="fig" rid="F1">Fig. 1B</xref> and normalized to the values in exponentially growing <italic>snf1</italic><sup><italic>as</italic></sup> cells (set to 1.0; n=4; + SEM; unpaired Student’s t-test, *p ≤ 0.05, **p ≤ 0.01) (G). (<bold>H</bold>) The phosphomimetic Pib2<sup>S268E,S309E</sup> is compromised for TORC1-binding. Kog1-HA<sub>3</sub>-expressing cells co-expressing Pib2-myc<sub>13</sub> (WT), Pib2<sup>S368A,S309A</sup>-myc<sub>13</sub> (SASA), Pib2<sup>S368E,S309E</sup>-myc<sub>13</sub> (SESE), or untagged Pib2 (-) were grown exponentially. Lysates (input) containing 60 mM glutamine and anti-myc immunoprecipitates (IP: anti-myc) were analyzed by immunoblotting with anti-HA and anti-myc antibodies, respectively. The mean relative amount of Kog1-HA<sub>3</sub> that was immunoprecipitated with Pib2-myc<sub>13</sub> and its variants was determined and normalized to the one between Kog1-HA<sub>3</sub> and Pib2-myc<sub>13</sub> (set to 1.0; n=4; + SEM; unpaired Student’s t-test, *p ≤ 0.05; nd, not detected). (<bold>I</bold>) Pib2-myc<sub>13</sub> alleles are adequately expressed. Expression of Pib2-myc<sub>13</sub> variants (as in F) was probed by immunoblot analysis in extracts of exponentially growing cells using anti-myc antibodies. Values were quantified relative to Adh1 levels (detected with anti-Adh1 antibodies) and normalized to the respective Pib2-myc<sub>13</sub>/Adh1 ratio in cells expressing the WT Pib2-myc<sub>13</sub> (n=3; ± SEM; unpaired Student’s t-test; nd, not detected).</p></caption><graphic xlink:href="EMS155982-f004"/></fig><fig id="F5" position="float"><label>Figure 5</label><caption><title>Snf1 phosphorylates Sch9-Ser<sup>288</sup> to antagonize Sch9-Thr<sup>737</sup> phosphorylation.</title><p>(<bold>A</bold>) Schematic representation of the structure of Sch9 with the C2 domain, the T-loop, the turn motif, and the hydrophobic motif (HM). The position of the potential Snf1 target residue (<italic>i</italic>.<italic>e</italic>. phosphorylated [P] Ser<sup>288</sup>) and one of the 5 C-terminal TORC1 target residues (<xref ref-type="bibr" rid="R114">Urban <italic>et al</italic>., 2007</xref>) (<italic>i</italic>.<italic>e</italic>. phosphorylated [P] Thr<sup>737</sup> in the HM motif that is used to probe TORC1 activity here) are indicated. (<bold>B</bold>) Phosphoproteomic analyses identify Sch9-Ser<sup>288</sup> as a potential Snf1 target. Mean phosphorylation levels of Sch9-Ser<sup>288</sup> in untreated (DMSO) and 2NM-PP1-treated <italic>snf1</italic><sup><italic>as</italic></sup> cells, grown exponentially (Exp) and limited for glucose (0.05% Glc) for the times indicated, were extracted from the SILAC experiment (<xref ref-type="supplementary-material" rid="SD2">Supplementary table 4</xref> and <xref ref-type="fig" rid="F3">Fig. 3</xref>) and normalized to the ones in exponentially growing cells (set to 1.0; n=3; + SD; unpaired Student’s t-test, *FDR ≤ 0.05). (<bold>C</bold>) Snf1 phosphorylates Ser<sup>288</sup> in Sch9 <italic>in vitro</italic>. Snf1 (WT) and kinase-inactive Snf1<sup>T210A</sup> (TA) were purified from yeast and used in protein kinase assays with [γ-<sup>32</sup>P]-ATP and the N-terminal fragment of Sch9 (encompassing the N-terminal 394 amino acids; Sch9<sup>1-394</sup>) as substrate (WT). In parallel protein kinase assays, we also used the respective Sch9<sup>1-394</sup> fragment harboring the Ser<sup>288</sup>-to-Ala mutation as substrate (S288A). Substrate phosphorylation was detected by autoradiography (left blot) and Sypro Ruby staining is shown as a loading control (right blot). The mean phosphorylation of the Sch9<sup>S288A</sup> mutant fragment by wild-type Snf1 (<italic>i</italic>.<italic>e</italic>. <sup>32</sup>P signal/Sypro Ruby [SyR] substrate input level; nd, not detected) was assessed relative to the one of the Sch9<sup>WT</sup> fragment (set to 1.0, n=3; ± SEM; unpaired Student’s t-test, *p ≤ 0.05; nd, not detected). (<bold>D</bold>) Snf1 controls Sch9-Ser<sup>288</sup> phosphorylation <italic>in vivo</italic>. Cells (<italic>i</italic>.<italic>e. snf1</italic><sup><italic>as</italic></sup>, <italic>snf1</italic><sup><italic>as</italic></sup> <italic>sch9</italic><sup><italic>S288A</italic></sup>, and <italic>snf1</italic><sup><italic>as</italic></sup> <italic>sch9</italic><sup><italic>S288E</italic></sup>) were grown exponentially on 2% glucose (Exp) and then starved for glucose (-C) in the absence (DMSO) or presence of 2NM-PP1 for the times indicated (upper row panels). In parallel, cells were grown exponentially (Exp) on low glucose media (0.05%; lower row panels) and then treated with vehicle (DMSO) or 2-NMPP1 for the times indicated. The levels of Ser<sup>288</sup> phosphorylation in Sch9 (Sch9-pSer<sup>288</sup>) and total levels of Sch9 were assayed by immunoblot analyses using anti-Sch9-pSer<sup>288</sup> and anti-Sch9 antibodies, respectively (n=3). (<bold>E</bold>) Snf1 binds Sch9. The binding affinity between Sch9<sup>1-394</sup> (purified from yeast) titrated against the Snf1 complex (also purified from yeast and containing the C-terminally GFP-tagged Snf4 γ-subunit) was assessed by microscale thermophoresis. The dissociation constant (K<sub>D</sub>; 95% profile likelihood = 3.2 – 19.1 nM; n=3; ± SEM) was calculated using a nonlinear asymmetric sigmoidal regression. (<bold>F, G</bold>) The phosphomimetic Sch9<sup>S288E</sup> allele compromises proper phosphorylation of the C-terminal Thr<sup>737</sup> residue in Sch9. <italic>snf1</italic><sup><italic>as</italic></sup>, <italic>snf1</italic><sup><italic>as</italic></sup> <italic>sch9</italic><sup><italic>S288A</italic></sup> (<italic>sch9</italic><sup><italic>SA</italic></sup>), and <italic>snf1</italic><sup><italic>as</italic></sup> <italic>sch9</italic><sup><italic>S288E</italic></sup> (<italic>sch9</italic><sup><italic>SE</italic></sup>) cells were grown exponentially (Exp) and then starved for 10 min for glucose (-C) in the absence (-; DMSO) or the presence (+) of 2NM-PP1. Immunoblot analyses of Sch9-pThr<sup>737</sup>, Sch9, Snf1-pThr<sup>210</sup>, and Snf1 were carried out as in <xref ref-type="fig" rid="F1">Fig. 1A (F)</xref>. The mean relative TORC1 activities in the three strains were quantified as in <xref ref-type="fig" rid="F1">Fig. 1B</xref> and normalized to the values in exponentially growing <italic>snf1</italic><sup><italic>as</italic></sup> cells (set to 1.0; n=5; + SEM; unpaired Student’s t-test, *p ≤ 0.05) (G).</p></caption><graphic xlink:href="EMS155982-f005"/></fig><fig id="F6" position="float"><label>Figure 6</label><caption><title>Physiological effects of Sch9<sup>S288E</sup> and Pib2<sup>S268E,S309E</sup> are additive.</title><p>(<bold>A, B</bold>) Exponentially growing (E) <italic>snf1</italic><sup><italic>as</italic></sup> cells expressing the indicated combinations of wild type Pib2 (Pib2 variant: WT), Pib2<sup>S268A,S309A</sup> (Pib2 variant: SASA), and Pib2<sup>S268E,S309E</sup> (Pib2 variant: SESE) and wild type Sch9 (Sch9 variant: WT), Sch9<sup>288A</sup> (Sch9 variant: SA), and Sch9<sup>S288E</sup> (Sch9 variant: SE) were starved for glucose (10 min) in the absence (-; DMSO; upper panels) and presence of 2NM-PP1 (+; lower panels). Immunoblot analyses were performed as in <xref ref-type="fig" rid="F1">Fig. 1A</xref> and the mean relative TORC1 activities (<italic>i</italic>.<italic>e</italic>. Sch9-pThr<sup>737</sup>/Sch9) were quantified, normalized relative to exponentially growing <italic>snf1</italic><sup><italic>as</italic></sup> cells (set to 1.0), and shown in the bar diagram in (B) (n=4; + SEM; unpaired Student’s t-test, *p ≤ 0.05). <bold>(C)</bold> Growth on media containing low nitrogen levels activates Snf1-Thr<sup>210</sup> phosphorylation and decreases TORC1 activity. WT cells were grown exponentially on SC or low nitrogen medium and assayed for their mean relative TORC1 activities (Sch9-pThr<sup>737</sup>/Sch9) and Snf1-Thr<sup>210</sup> phosphorylation levels (Snf1-pThr<sup>210</sup>/Snf1), each normalized to the values of cells grown on SC (set to 1.0; n=8; ± SEM). In unpaired Student’s tests, both values in cells growing on low nitrogen medium were significantly different form the ones growing on SC (*p ≤ 0.05). (<bold>D, E</bold>) Combined expression of Sch9<sup>S288E</sup> and Pib2<sup>S268E,S309E</sup> causes reduced Sch9-Thr<sup>737</sup> phosphorylation (D) and enhanced rapamycin sensitivity (E). In (D), indicated strains were grown exponentially on low nitrogen medium and assayed for their mean TORC1 activities as in (C), which were normalized to the value of WT cells (set to 1.0; n=4; ± SEM; unpaired Student’s t-test, *p ≤ 0.05). In (E), cells with the indicated genotypes were grown exponentially in SD, then 10-fold serially diluted, spotted on control plates (SD) or 2.5 nM rapamycin-containing plates, and grown for 3 days at 30°C (n=4).</p></caption><graphic xlink:href="EMS155982-f006"/></fig></floats-group></article>